
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCBAAA9926513B33DAAA90011F50B70.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="nar">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8191791/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Nucleic Acids Research">
<meta name="citation_title" content="Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance">
<meta name="citation_author" content="Miyoung Lee">
<meta name="citation_author_institution" content="Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK">
<meta name="citation_author" content="David Shorthouse">
<meta name="citation_author_institution" content="Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK">
<meta name="citation_author" content="Robert Mahen">
<meta name="citation_author_institution" content="Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK">
<meta name="citation_author" content="Benjamin A Hall">
<meta name="citation_author_institution" content="Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK">
<meta name="citation_author" content="Ashok R Venkitaraman">
<meta name="citation_author_institution" content="Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK">
<meta name="citation_author_institution" content="The Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599 &amp; Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove 138648, Singapore">
<meta name="citation_publication_date" content="2021 May 12">
<meta name="citation_volume" content="49">
<meta name="citation_issue" content="10">
<meta name="citation_firstpage" content="5588">
<meta name="citation_doi" content="10.1093/nar/gkab308">
<meta name="citation_pmid" content="33978741">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8191791/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8191791/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8191791/pdf/gkab308.pdf">
<meta name="description" content="Cancer-causing missense mutations in the 3418 amino acid BRCA2 breast and ovarian cancer suppressor protein frequently affect a short (∼340 residue) segment in its carboxyl-terminal domain (DBD). Here, we identify a shared molecular mechanism ...">
<meta name="og:title" content="Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Cancer-causing missense mutations in the 3418 amino acid BRCA2 breast and ovarian cancer suppressor protein frequently affect a short (∼340 residue) segment in its carboxyl-terminal domain (DBD). Here, we identify a shared molecular mechanism ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8191791/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="8191791">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1093/nar/gkab308"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/gkab308.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8191791%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/8191791/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/8191791/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8191791/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/narlogo.gif" alt="Nucleic Acids Research logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Nucleic Acids Research" title="Link to Nucleic Acids Research" shape="default" href="https://doi.org/10.1093/nar/gkab308" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Nucleic Acids Res</button></div>. 2021 May 12;49(10):5588–5604. doi: <a href="https://doi.org/10.1093/nar/gkab308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1093/nar/gkab308</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Nucleic%20Acids%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nucleic%20Acids%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Nucleic%20Acids%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Nucleic%20Acids%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Cancer-causing <em>BRCA2</em> missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Miyoung Lee</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Miyoung Lee</span></h3>
<div class="p">
<sup>1</sup>
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Miyoung Lee</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shorthouse%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">David Shorthouse</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">David Shorthouse</span></h3>
<div class="p">
<sup>2</sup>
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shorthouse%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">David Shorthouse</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mahen%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Robert Mahen</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Robert Mahen</span></h3>
<div class="p">
<sup>3</sup>
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mahen%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Robert Mahen</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hall%20BA%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Benjamin A Hall</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Benjamin A Hall</span></h3>
<div class="p">
<sup>4</sup>
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hall%20BA%22%5BAuthor%5D" class="usa-link"><span class="name western">Benjamin A Hall</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Venkitaraman%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Ashok R Venkitaraman</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Ashok R Venkitaraman</span></h3>
<div class="p">
<sup>5</sup>
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK</div>
<div class="p">
<sup>6</sup>
The Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599 &amp; Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove 138648, Singapore</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Venkitaraman%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ashok R Venkitaraman</span></a>
</div>
</div>
<sup>5,</sup><sup>6,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK</div>
<div id="aff2">
<sup>2</sup>
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK</div>
<div id="aff3">
<sup>3</sup>
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK</div>
<div id="aff4">
<sup>4</sup>
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK</div>
<div id="aff5">
<sup>5</sup>
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK</div>
<div id="aff6">
<sup>6</sup>
The Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599 &amp; Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove 138648, Singapore</div>
<div class="author-notes p"><div class="fn" id="COR1">
<sup>✉</sup><p class="display-inline">To whom correspondence should be addressed. Tel: +65 6516 1159; Email: <span>arv22@nus.edu.sg</span></p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Accepted 2021 Apr 28; Revised 2021 Apr 11; Received 2020 Nov 3; Collection date 2021 Jun 4.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.</div>
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC8191791  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33978741/" class="usa-link">33978741</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Cancer-causing missense mutations in the 3418 amino acid BRCA2 breast and ovarian cancer suppressor protein frequently affect a short (∼340 residue) segment in its carboxyl-terminal domain (DBD). Here, we identify a shared molecular mechanism underlying their pathogenicity. Pathogenic BRCA2 missense mutations cluster in the DBD’s helical domain (HD) and OB1-fold motifs, which engage the partner protein DSS1. Pathogenic - but not benign – DBD mutations weaken or abolish DSS1-BRCA2 assembly, provoking mutant BRCA2 oligomers that are excluded from the cell nucleus, and disable DNA repair by homologous DNA recombination (HDR). DSS1 inhibits the intracellular oligomerization of wildtype, but not mutant, forms of BRCA2. Remarkably, DSS1 expression corrects defective HDR in cells bearing pathogenic BRCA2 missense mutants with weakened, but not absent, DSS1 binding. Our findings identify a DSS1-mediated intracellular protein assembly mechanism that is disrupted by cancer-causing BRCA2 missense mutations, and suggest an approach for its therapeutic correction.</p></section><section class="abstract" id="abstract2"><h2>Graphical Abstract</h2>
<figure class="fig xbox font-sm" id="ga1"><h3 class="obj_head">Graphical Abstract.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8191791/02d5ce6c4ad1/gkab308gra1.jpg" loading="lazy" height="247" width="481" alt="Graphical Abstract"></p>
<div class="p text-right font-secondary"><a href="figure/ga1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Cancer-causing mutations in the BRCA2 DBD impair DSS1 binding, provoking intracellular oligomerization and cytosolic mis-localization of the mutant BRCA2, and defective homologous recombination. These defects are reversed by DSS1 overexpression, for certain DBD mutants that retain small amounts of DSS1 binding.</p></figcaption></figure></section><section id="SEC1"><h2 class="pmc_sec_title">INTRODUCTION</h2>
<p>Germline mutations affecting <em>BRCA2</em> increase susceptibility to breast, ovarian, prostatic and pancreatic cancers (<a href="#B1" class="usa-link" aria-describedby="B1">1–5</a>). Over 12 000 different pathogenic mutations and benign variants have been reported across the entire ∼100 kB span of the human <em>BRCA2</em> gene [ClinVar database (<a href="https://www.ncbi.nlm.nih.gov/clinvar/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/clinvar/</a>)]. Mutations that truncate the encoded BRCA2 protein through frameshift, nonsense codon insertion, or altered splicing are largely considered pathogenic (<a href="#B6" class="usa-link" aria-describedby="B6">6</a>,<a href="#B7" class="usa-link" aria-describedby="B7">7</a>). However, &gt;50% of <em>BRCA2</em> mutations described in the ClinVar database are missense mutations that cause non-synonymous alterations in the BRCA2 protein. Over 90% of these mutations are either classified as variants of unknown significance (VUS), or come with conflicting interpretations of pathogenicity, raising a major clinical challenge for the management of risk in mutation carriers. International collaborative efforts (<a href="#B6" class="usa-link" aria-describedby="B6">6–12</a>) combining parameters as wide-ranging as evolutionary conservation of affected residues, or multifactorial likelihood estimates from affected families, have analysed 143 BRCA2 missense mutations via expert panel review to assess pathogenicity with a stringent level of supporting evidence (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>). We have investigated here the molecular mechanisms by which a frequently occurring group of these panel-reviewed mutations might affect the biological functions of BRCA2 to cause pathogenicity.</p>
<p>Available evidence indicates that BRCA2 plays an essential role in maintaining human genome integrity through its roles in four biological processes (reviewed in (<a href="#B14" class="usa-link" aria-describedby="B14">14</a>)). It controls the localization and assembly on DNA substrates of the recombination enzyme, RAD51, during DNA repair by homologous DNA recombination (HDR) (<a href="#B15" class="usa-link" aria-describedby="B15">15–18</a>); protects the structure of stalled DNA replication forks (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>,<a href="#B20" class="usa-link" aria-describedby="B20">20</a>); suppresses unscheduled RNA-DNA hybrid (R-loop) formation through the regulation of nuclear RNA export and/or promoter-proximal RNA polymerase II pausing (<a href="#B21" class="usa-link" aria-describedby="B21">21</a>,<a href="#B22" class="usa-link" aria-describedby="B22">22</a>); and has been implicated directly or indirectly in events leading to chromosome segregation (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>,<a href="#B24" class="usa-link" aria-describedby="B24">24</a>). Moreover, non-homologous end-joining is activated in BRCA2-deficient cells via an Artemis-dependent mechanism (<a href="#B25" class="usa-link" aria-describedby="B25">25</a>), but there is little evidence that BRCA2 is a direct mediator of this repair process.</p>
<p>BRCA2 is localized to its major site of activity via nuclear localization signals (NLSs) at its extreme carboxyl-terminus (<a href="#B26" class="usa-link" aria-describedby="B26">26</a>,<a href="#B27" class="usa-link" aria-describedby="B27">27</a>), but contains few other protein motifs of known function. It may instead work as a hub for the assembly of macromolecular complexes that maintain genome stability through the coordination of different biological processes (reviewed in (<a href="#B14" class="usa-link" aria-describedby="B14">14</a>)). For instance, eight conserved sequence motifs of ∼35 residues each (the BRC repeats) in human BRCA2, interact with RAD51, and regulate the assembly of ordered nucleoprotein filaments on DNA substrates (<a href="#B15" class="usa-link" aria-describedby="B15">15–17</a>,<a href="#B28" class="usa-link" aria-describedby="B28">28–31</a>). The N-terminal region of BRCA2 engages a chromatin-bound partner, PALB2, which recruits BRCA2 and RAD51 to sites of DNA damage (<a href="#B32" class="usa-link" aria-describedby="B32">32</a>). Notably, a carboxyl-terminal domain (DSS1/DNA-binding domain; DBD) spanning residues 2457–3184 in BRCA2 binds to a small (∼70 residue) acidic partner, DSS1, to form structures that mediate binding to single- (ss-) or double- (ds) stranded DNA. A crystallographic structure of the BRCA2 DBD reveals that DSS1 binds to the helical domain (HD), and the first (OB1) of three oligonucleotide-/oligosaccharide- binding OB folds. OB2 and OB3 engage ssDNA, while the so-called tower domain contains a helix-loop-helix motif capable of dsDNA-binding (<a href="#B33" class="usa-link" aria-describedby="B33">33</a>). DSS1 binding to the BRCA2 DBD has been shown to be essential for its solubility and stability (<a href="#B33" class="usa-link" aria-describedby="B33">33–35</a>), suggestive of a role in protein folding. The DSS1/DBD complex is reported to be essential for the nuclear transport of BRCA2/RAD51 complexes (<a href="#B36" class="usa-link" aria-describedby="B36">36</a>), and loading of RAD51 on RPA-coated ssDNA to initiate HDR (<a href="#B33" class="usa-link" aria-describedby="B33">33</a>,<a href="#B37" class="usa-link" aria-describedby="B37">37</a>,<a href="#B38" class="usa-link" aria-describedby="B38">38</a>).</p>
<p>Here, we have analysed 9 known pathogenic BRCA2 missense mutations, and report that a common molecular mechanism underlies their pathogenicity. Remarkably, 8 of these 9 pathogenic mutations cluster within the HD and OB1 fold of the BRCA2 DBD, with 1, R3052W, at the OB2/OB3 junction. We find that all these mutations diminish the DSS1/BRCA2 DBD interaction, and present evidence that they disrupt a DSS1-mediated protein assembly mechanism required for nuclear import, to disable HDR. Interestingly, expression of DSS1 can ameliorate defective nuclear transport and correct HDR in cells bearing several hypomorphic BRCA2 missense mutations that diminish but do not ablate DSS1 binding. Collectively, our findings identify a shared molecular mechanism that underlies the pathogenicity of BRCA2 missense mutants that cluster in the DBD and suggest an approach for their therapeutic correction.</p></section><section id="SEC2"><h2 class="pmc_sec_title">MATERIALS AND METHODS</h2>
<section id="SEC2-1"><h3 class="pmc_sec_title">Cell culture and transfections</h3>
<p>HeLa Kyoto (from the laboratory of Jonathan Pines) and 293T (ATCC) cells were cultured in DMEM (Gibco) supplemented with 10% FBS (Gibco) and maintained at 37°C with 5% CO<sub>2</sub>. JetPRIME transfection reagent (Polyplus Transfection, 114-07) was used for all transfections according to the manufacturer's instruction.</p></section><section id="SEC2-2"><h3 class="pmc_sec_title">Molecular cloning and mutagenesis</h3>
<p>For mammalian expression, GFP-BRCA2<sup>CT</sup> plasmids were made by cloning a 3 kb <em>BRCA2</em> cDNA fragment encoding residues 2432–3418 into the XhoI/SalI sites of the pEGFP C1 vector (Clontech). DBD mutations were introduced by PCR using two complementary primers (∼40nt) containing mutated sequences and DpnI digestion of the template before transformation of DH5α. The 0.21 kb human DSS1 cDNA was cloned into <em>Xba</em>I site of pcDNA3.1 Hygro 5x Myc vector to make the Myc-DSS1 plasmid. mCherry- and paGFP- BRCA2<sup>CT</sup> plasmids were made by replacing the GFP sequence of GFP-BRCA2<sup>CT</sup> plasmids with 0.74 kb mCherry or paGFP cDNA fragment at NheI/BspE1 sites.</p>
<p>For bacterial expression, GST-BRCA2<sup>CT</sup> plasmids contained 3 kb <em>BRCA2</em> cDNA fragments encoding human residues 2432–3418, cloned into the SalI/NotI sites of pGEX-4T3 vector (GE Healthcare). Similarly, GFP-BRCA2<sup>CT</sup> plasmids were cloned from 3.7 kb cDNA fragments encoding an N-terminal GFP tag fused to human BRCA2 residues 2432–3418 region, which were PCR-amplified from the GFP-BRCA2<sup>CT</sup> construct (in the pEGFP C1 vector) and cloned into the NdeI/NotI sites of the pET21a vector (C-terminal His-tag, Novagen).</p></section><section id="SEC2-3"><h3 class="pmc_sec_title">Generation of mutant cell lines by genome editing</h3>
<p>BRCA2 DBD missense mutations were introduced into HeLa Kyoto cells using CRISPR protocols developed by the Zhang lab (<a href="#B39" class="usa-link" aria-describedby="B39">39</a>). Briefly, sgRNA sequences targeting W2626 and D2723 residues were designed using GPP sgRNA Designer (<a href="https://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-design" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-design</a>). sgRNA sequences were cloned into PX458 vector (Addgene Plasmid #48138). Single-stranded DNA oligonucleotides (ssODNs) containing the mutations and diagnostic restriction enzyme sites were synthesized by Integrated DNA Technologies (IDT) and used as HDR templates (<a href="#sup1" class="usa-link">Supplementary Table S3</a>). HeLa Kyoto cells plated in 12-well plates were transfected with 0.5 μg PX458 plasmids expressing sgRNAs/Cas9/GFP and 1 μl of 10 μM HDR templates. Two days after transfection, GFP-positive cells were flow-sorted to enrich transfected cells and single cells were plated in 96-well plates. Clones were screened by PCR amplifying target regions and diagnostic restriction enzyme digestion of the PCR products. Positive clones were confirmed by sequencing of the PCR products and further validated by cloning PCR products into pCR Blunt vector (Invitrogen) and sequencing. Two independent clones per each mutation were validated and used for functional analysis.</p>
<p>To generate a <em>BRCA2</em> knock-out (KO) cell line, HeLa Kyoto cells were co-transfected with BRCA2 CRISPR/Cas9 KO Plasmid (h) (sc-400700, Santa Cruz Biotechnology) and BRCA2 HDR Plasmid (h) (sc-400700-HDR, Santa Cruz Biotechnology, selection marker: puromycin resistance, RFP). Single clones resistant to puromycin (1 μg/ml) were isolated and screened by western blotting for BRCA2. sc-400700 is a pool of the three sgRNA plasmids: sc-400700 A (CTGTCTACCTGACCAATCGA); sc-400700 B (ATGTAGCACGCATTCACATA); sc-400700 C (CGATTACCTGTGTACCCTTT).</p></section><section id="SEC2-4"><h3 class="pmc_sec_title">Immunoprecipitation and western blotting</h3>
<p>For immunoprecipitation, 293T cells transfected with the expression constructs were lysed in the NP40 lysis buffer (50 mM HEPES (pH 7.4), 150 mM NaCl, 0.5% NP-40, 1 mM EDTA, 20 mM β-glycerophosphate, 1 mM DTT and protease inhibitor cocktail (Roche, 11873580001)). 1mg of protein extracts were incubated with 1 μl of α-GFP antibody (rabbit, Clontech, 632592) at 4°C overnight. Immune complexes were collected with Protein A Sepharose 4B beads (Sigma, P9424) and washed 3 times with the NP40 lysis buffer before electrophoresis. For western blotting, samples were loaded on either 3–8% Tris-acetate gels or 4–12% Bis–Tris gels (Invitrogen) and transferred to PVDF membrane (Immobilon-P, Millipore). For detection of Myc-DSS1, membranes were treated with 0.2% glutaraldehyde (Sigma) for 45 min before blocking. Primary antibodies used were α-BRCA2 (Ab-1, clone 2B, Merck Millipore OP95, 1:500; clone 5.23, Merck Millipore, 05-666, 1:2000), α-RAD51 (clone 14B4, GeneTex, GTX70230, 1:1000), α-GFP (clone JL-8, Clontech, 632381,1:1000), α-mCherry (α-dsRed, Clontech, 632496, 1:1000), α-Myc (clone 9E10, Santa Cruz, sc-40, 1:500), and α-MEK2 (BD Transduction, 610235, 1:1000). Membranes were incubated with primary and secondary antibodies (HRP-conjugated) diluted in the blocking solution (5% skimmed milk in TBS/Tween buffer (0.1%Tween20/TBS (50 mM Tris–HCl, 150 mM NaCl))) and developed using ECL reagent (GE Healthcare).</p></section><section id="SEC2-5"><h3 class="pmc_sec_title">Nucleocytoplasmic localization (microscopy)</h3>
<p>Cells grown on coverslips in six-well plates were transfected with GFP-BRCA2<sup>CT</sup> plasmids. Twenty-four hours later, cells were fixed with 4% PFA (Agar Scientific) for 10 min and permeabilized with TBS–Triton buffer (0.1% Triton-X100/TBS) for 5 min before mounting with Dako Fluorescence Mounting Medium (Dako S3023) containing DAPI (1.5 μg/ml, Sigma). Images acquired with LSM 880 confocal microscope (Zeiss) were analysed using Cell Profiler Human cytoplasm-nucleus translocation assay pipeline. GFP mean intensity in nucleus was divided by mean intensity in cytoplasm to give nucleocytoplasmic ratio.</p></section><section id="SEC2-6"><h3 class="pmc_sec_title">Native gel electrophoresis</h3>
<p>Samples were prepared in the native lysis buffer (50 mM HEPES (pH 7.4), 50 mM NaCl, 2 mM MgCl<sub>2</sub>, 0.5% NP40, Benzonase 1 U/μl, proteinase inhibitor cocktail). NativePAGE 5% G-250 Sample Additive (ThermoFisher, BN2004) was added to the samples at a final concentration of 0.125%. Samples were separated on NativePAGE Novex 3–12% Bis–Tris Protein Gels (ThermoFisher, BN1001BOX) for 2 h at 150 V. Dark blue cathode buffer was replaced with light blue cathode buffer during the run. Proteins transferred to PVDF membrane were fixed with 8% acetic acid for 15 min and processed for western blotting.</p></section><section id="SEC2-7"><h3 class="pmc_sec_title">Nucleocytoplasmic fractionation</h3>
<p>Nuclear and cytoplasmic fractions were prepared from BRCA2 mutant cell lines using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific, 78833) according to the manufacturer's instruction. Briefly, pellets of 1 × 10<sup>6</sup> cells were resuspended in 100 μl of CER I reagent, vortexed, and incubated on ice for 10 min. After addition of 5.5 μl of CER II reagent, samples were vortexed and incubated on ice for 1 min. Samples were centrifuged for 5 min at 16 000 × g to obtain cytoplasmic fractions (supernatant). Pellets (nuclei) were resuspended in 50 μl of NER reagent and incubated on ice for 40 min with vortexing every 10 min. After centrifugation at 16 000 × g for 10 min, nuclear fractions (supernatant) were collected. Nuclear and cytoplasmic fractions were analysed by western blotting.</p></section><section id="SEC2-8"><h3 class="pmc_sec_title">mClover Lamin A HDR assay</h3>
<p>Cells grown on coverslips in six-well plates were transfected with sgRNA plasmid targeting Lamin A (pUC CBA-SpCas9.EF1a-BFP.sgLMNA, Addgene Plasmid #98971) and donor plasmid (pCAGGS Donor mClover-LMNA, Addgene Plasmid #98970). Three days later, cells were fixed with 4% PFA for 10 min and permeabilized with TBS-Triton buffer for 5 min before mounting with DAPI containing medium. Images acquired with LSM 880 microscope were analysed with ImageJ. HDR positive cells were defined as cells with mean mClover nuclear intensity over a threshold set for each experiment (<a href="#B40" class="usa-link" aria-describedby="B40">40</a>,<a href="#B41" class="usa-link" aria-describedby="B41">41</a>).</p></section><section id="SEC2-9"><h3 class="pmc_sec_title">paGFP nuclear import assay</h3>
<p>Cells plated in μ-slide 8 well glass bottom chamber slides (ibidi, 80827) were transfected with paGFP-BRCA2<sup>CT</sup> plasmids. Before live imaging, media was changed to Leibovitz's L-15 medium, no phenol red (ThermoFischer, 21083027) containing 10% FBS. Photoactivation and imaging were performed with LSM 880 confocal microscope. For photoactivation, bleaching tool in Zen software was used with 405 nm laser at 100% intensity, with 50 iterations. Approximately 4.41 μm<sup>2</sup> area in cytoplasm was activated. Fluorescence intensity in the activated area and the same size area in nucleus were measured for 3 min in time-lapse imaging. For analysis, after background subtraction, fluorescence intensity was normalized to maximum intensity (intensity at peak) in each cell to obtain relative intensity. Mean relative intensity from 8 to 10 cells per sample was plotted with Graphpad Prism.</p></section><section id="SEC2-10"><h3 class="pmc_sec_title">DSS1 depletion</h3>
<p>HeLa cells were transfected with DSS1 siRNA (Horizon, Dharmacon siGENOME Human SEM1 siRNA-SMARTpool, M-021353-00-0005) or control siRNA (Horizon, Dharmacon On-TARGET plus Non targeting–pool, D-001810-10-05) using JetPRIME transfection reagent (final siRNA concentration: 30 nM). For nucleocytoplasmic distribution of the GFP-BRCA2<sup>CT</sup> fragment, HeLa cells were transfected with the siRNAs 24 h before transfecting with the GFP-BRCA2<sup>CT</sup> construct. For the subcellular fractionation experiment, HeLa cells were transfected with the siRNAs 48 h before fractionation. DSS1 siRNA sequences: siRNA-D-021353-01 (GCACAUGUCUGGGAGGAUA); siRNA-D-021353-02 (GUUAUAAGAUGGAGACUUC); siRNA-D-021353-03 (AGACUGGGCUGGCUUAGAU); siRNA-D-021353-04 (CAAUGUAGAGGAUGACUUC)</p></section><section id="SEC2-11"><h3 class="pmc_sec_title">RT-qPCR assay</h3>
<p>1 μg of RNA samples extracted from the cell pellets using RNeasy Plus mini kit (Qiagen, 74134) were converted to cDNAs using FastGene Scriptase II cDNA Kit (Geneflow, P8-0054) according the manufacturer's instruction. cDNAs were analyzed by qPCR using LightCycler 480 SYBR Green I Master reagent (Roche, 04887352001). DSS1 mRNA level was normalized to HPRT mRNA level.</p>
<p>Primers for DSS1 cDNA: Forward Primer (GAAAAAGCAGCCGGTAGACTT); Reverse Primer (ATCCCAATTATCCTCCCAGACA)</p>
<p>Primers for HPRT cDNA: Forward Primer (TGACACTGGCAAAACAATGCA); Reverse Primer (GGTCCTTTTCACCAGCAAGCT)</p></section><section id="SEC2-12"><h3 class="pmc_sec_title">Purification of BRCA2<sup>CT</sup> protein fragments</h3>
<p>To purify GST-BRCA2<sup>CT</sup> fragments, <em>Escherichia coli</em> BL21(DE3) cells transformed with the GST-BRCA2<sup>CT</sup> constructs (pGEX-4T3 vector) were induced with 0.1 mM IPTG at 21°C overnight. Bacterial pellets were resuspended in PBS (containing 5 mM DTT + protease inhibitor cocktail) and sonicated on ice for lysis. NP-40 was added to the lysates (final concentration of 0.5%) and the lysates were rotated at 4°C for 30 min. After centrifugation (12 000 × g, for 10 min), the supernatants were incubated with the Glutathione Sepharose 4B beads (GE Healthcare, 17-0756-01) at 4°C overnight. The beads were washed with PBS containing 0.5% NP-40 four times and resuspended in PBS containing 5 mM DTT.</p>
<p>To purify GFP-BRCA2<sup>CT</sup> fragments, <em>E. coli</em> BL21(DE3) cells transformed with the GFP-BRCA2<sup>CT</sup> constructs (pET21a vector, C-terminal His-tag) were induced with 0.1 mM IPTG at 27°C for 3 h. Bacterial pellets were resuspended in the His-purification buffer (20% glycerol, 50 mM sodium phosphate (pH 8.0), 300 mM NaCl, EDTA-free protease inhibitor cocktail) + 5 mM imidazole) and sonicated on ice for lysis. Triton X-100 was added to the lysates (final concentration of 0.5%) and the lysates were rotated at 4°C for 30 min. After centrifugation (12 000 × g, for 10 min), the supernatants were incubated with the Ni-NTA Agarose beads (Qiagen, 30210) at 4°C overnight. The beads were washed with the His-purification buffer containing 0.5% Triton X-100 twice and then with the His-purification buffer containing 20 mM Imidazole twice. GFP-BRCA2<sup>CT</sup> fragments were eluted with the His-purification buffer containing 50 mM Imidazole and 250 mM imidazole (three fractions each).</p>
<p>Purified proteins were analysed by Coomassie blue staining and western blotting for GFP (GFP-BRCA2<sup>CT</sup> fragments) or BRCA2 C-terminal residues (anti-BRCA2 antibody, clone 5.23, Merck Millipore, 05-666, both GST- and GFP-BRCA2<sup>CT</sup> fragments).</p></section><section id="SEC2-13"><h3 class="pmc_sec_title">GST-pull down assay</h3>
<p>GST-BRCA2<sup>CT</sup> fragments bound to the Glutathione Sepharose 4B beads were pre-incubated in the binding buffer (150 mM NaCl, 0.5% NP-40, 50 mM Tris.Cl (pH 7.4), 1 mM EDTA, 0.1% BSA, protease inhibitor cocktail) at room temperature for 20 min. After adding the GFP-BRCA2<sup>CT</sup> fragments, the beads were incubated at room temperature for 1 h before washing with the binding buffer four times. Bound proteins were analysed by western blotting with the anti GFP antibody.</p></section><section id="SEC2-14"><h3 class="pmc_sec_title">ΔΔG/RSA calculations</h3>
<p>For calculating the ΔΔG/RSA for each mutation/residue, we first curated each crystal structure. Structures were downloaded from the protein data bank, non-protein molecules were removed from the structures, and the structure was relaxed using the Foldx RelaxPDB command within Foldx5 (<a href="#B42" class="usa-link" aria-describedby="B42">42</a>). The full command used for relaxation was:</p>
<ul class="list" style="list-style-type:none"><li><p>$foldx -command=RepairPDB -pdb=1MJE.pdb -ionStrength=0.05 -pH=7 -vdwdDesign=2</p></li></ul>
<p>ΔΔ<em>G</em> was calculated using Foldx Positionscan command within Foldx5. Positionscan was run on each residue in the structure and the results for residues of interest extracted. The command used for Positionscan was:</p>
<ul class="list" style="list-style-type:none"><li><p>$foldx -command=PositionScan -pdb=1MJE repair.pdb -ionStrength=0.05 -pH=7 -vdwdDesign=2 -pdbHydrogens=false -positions=100</p></li></ul>
<p>for calculating the ΔΔ<em>G</em> of each mutation at residue 100.</p>
<p>RSA was calculated using the BioPython python module (<a href="#B43" class="usa-link" aria-describedby="B43">43</a>).</p></section><section id="SEC2-16"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>Statistical analysis was conducted using Graphpad Prism software (v5). Statistical tests used are listed in the relevant figure legends. <em>P</em>-value summary for all statistical tests used in this study is: ns, <em>P</em>-value &gt; 0.05; *<em>P</em>-value ≤ 0.05; **<em>P</em>-value ≤ 0.01; ***<em>P</em>-value ≤ 0.001.</p></section></section><section id="SEC3"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="SEC3-1"><h3 class="pmc_sec_title">Clustering of pathogenic BRCA2 missense mutations within the DBD</h3>
<p>We analysed 9085 variants of BRCA2 found in the ClinVar database, for which both molecular consequence and clinical significance have been reported (Figure <a href="#F1" class="usa-link">1A</a> and <a href="#sup1" class="usa-link">Supplementary Table S1</a>). Over 50% (5442 variants) encoded missense variants, of which 148 variants were classified as benign, and 37 variants, pathogenic. Assertions of pathogenicity in ClinVar are based on varying levels of evidence (<a href="http://www.ncbi.nlm.nih.gov/clinvar/docs/review_status/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.ncbi.nlm.nih.gov/clinvar/docs/review_status/</a>). To ensure a stringent threshold of evidence supporting their classification, we confined our analysis to 143 <em>BRCA2</em> missense mutations (Figure <a href="#F1" class="usa-link">1B</a> and <a href="#sup1" class="usa-link">Supplementary Table S2</a>) that had been reviewed by an expert panel (<a href="https://enigmaconsortium.org/;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://enigmaconsortium.org/;</a> (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>)), excluding mutations affecting the first Met residue in <em>BRCA2</em> (which perturb protein translation, c.3G&gt;A (M1I, M231I)). Thirteen of these 143 <em>BRCA2</em> mutations were deemed pathogenic by expert panel review (as of 2020.07.27).</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8191791_gkab308fig1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8191791/7445a6d0423a/gkab308fig1.jpg" loading="lazy" height="779" width="654" alt="Figure 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Clustering of pathogenic <em>BRCA2</em> missense mutations within the DBD. (<strong>A</strong>) Clinical significance of <em>BRCA2</em> mutations by mutation type. The graph shows 9085 variants classified by molecular consequence (mutation type) and clinical significance, out of a total of 12 684 <em>BRCA2</em> variants listed in the ClinVar database (version of 2020.07.27). (<strong>B</strong>) Clinical significance of 143 <em>BRCA2</em> missense mutations reviewed by the expert panel are shown. Pathogenic mutations clustered in the DBD are marked with a blue circle. The schematic shows human BRCA2 protein structure. Amino acid residue numbers are marked. HD, helical domain: OB, oligonucleotide/oligosaccharide binding; TD, tower domain; NLS, nuclear localisation signal. (<strong>C</strong>) Location of each pathogenic mutation within the BRCA2 DBD.</p></figcaption></figure><p>Remarkably, 12 of these 13 pathogenic missense mutations cluster within the DBD. By contrast, the remaining missense mutations are distributed across whole length of the BRCA2 protein (Figure <a href="#F1" class="usa-link">1B</a> and <a href="#sup1" class="usa-link">Supplementary Table S2</a>). Moreover, 10/12 pathogenic mutations in the DBD affect the HD and OB1 fold, implicated in DSS1 binding (<a href="#B33" class="usa-link" aria-describedby="B33">33</a>), whilst a singleton mutation (R3052W) affects the OB2/OB3 junction, and another singleton (N3124I) falls in OB3 (Figure <a href="#F1" class="usa-link">1C</a>). We report below mechanistic analyses of 9 pathogenic mutants (W2626C, I2627F, R2659T, E2663V, T2722R, D2723H, D2723G, G2748D and R3052W), which are collectively representative of pathogenic <em>BRCA2</em> DBD mutations, and compare them to 2 benign variants (T2515I, K2729N), as well as wild-type BRCA2. Of note, the pathogenic mutant R2659T has been reported to alter <em>BRCA2</em> splicing, leading to the in-frame deletion of 57 amino acids encoded in exon 17, and the absence of mutant protein (<a href="#B44" class="usa-link" aria-describedby="B44">44</a>); it may not therefore represent a biologically significant <em>BRCA2</em> mis-sense mutant.</p></section><section id="SEC3-2"><h3 class="pmc_sec_title">Pathogenic BRCA2 mutations in the DBD affect DSS1 binding</h3>
<p>The clustering of <em>BRCA2</em> pathogenic missense mutations in the HD and OB1 regions of the DBD prompted us to investigate their effect on DSS1 binding. To this end, we expressed in 293T cells constructs encoding green fluorescent protein (GFP) fused to either wild-type (WT) or mutant forms of the carboxyl-terminal one-third of BRCA2 (GFP-BRCA2<sup>CT</sup>), spanning residues 2432 to 3418, encompassing the DBD and NLSs (Figure <a href="#F2" class="usa-link">2A</a>). As expected, GFP-BRCA2<sup>CT</sup> WT could be co-immunoprecipitated with co-expressed Myc-epitope tagged DSS1 (Myc-DSS1). Mutant forms of GFP-BRCA2<sup>CT</sup> encoding the benign variants T2515I (in the HD) or K2729N (in the OB1) also interacted with Myc-DSS1 (Figure <a href="#F2" class="usa-link">2B</a>, lanes 2, 3 and 4).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8191791_gkab308fig2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8191791/ed43c896360c/gkab308fig2.jpg" loading="lazy" height="1033" width="724" alt="Figure 2."></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Pathogenic BRCA2 mutations in the DBD affect DSS1 binding and nuclear localization. (<strong>A</strong>) List of pathogenic (red) or benign (blue) mutations in the DBD analysed in this study with a schematic of the expression construct, GFP-BRCA2<sup>CT</sup>. (<strong>B</strong> and <strong>C</strong>) Interaction between the DBD mutants and DSS1. Wild-type or mutant forms of GFP-BRCA2<sup>CT</sup> were transiently expressed with Myc-DSS1 in 293T cells. Interaction was detected by anti GFP-IP and western blotting with anti-Myc antibody. The graph (<strong>C</strong>) shows DSS1-binding activity of the mutants normalised to the WT value. Binding activity was assessed by quantifying the intensity of the Myc-DSS1 bands pulled-down by IP. Data are presented as mean ± s.e. from three repeats. Statistical significance was assessed by 1-way ANOVA test, followed by Dunnett's multiple comparison test (compared to WT). (D and E) Nucleocytoplasmic distribution of the DBD mutants. HeLa cells transiently expressing GFP-BRCA2<sup>CT</sup> fragments were fixed with PFA before imaging. The graph (<strong>E</strong>) shows the GFP intensity ratio (nuclear/cytoplasmic, mean ± s.e.). More than 100 cells per sample were analysed. Statistical significance was assessed by the Kruskal-Wallis test, followed by Dunnett's multiple comparison test (compared to WT). A representative result from two independent experiments is shown. (<strong>D</strong>) shows representative microscopic images. Scale bar, 10μm.</p></figcaption></figure><p>In contrast, GFP-BRCA2<sup>CT</sup> bearing pathogenic mutations exhibited reduced or undetectable binding to Myc-DSS1. Notably, different pathogenic mutants were differentially affected, with the following order of DSS1 binding - D2723H, D2723G (<em>lowest</em> DSS1 binding) &lt; T2722R &lt;&lt; I2627F &lt; R2659T &lt; G2748D &lt;&lt; E2663V &lt; W2626C (<em>highest</em> DSS1 binding). The pathogenic W2626C and E2663V mutants were least affected. The remaining pathogenic mutants all showed a marked decrease, with undetectable DSS1 binding in the D2723H and D2723G mutants, which affect a key Asp residue in the OB1-fold, as well as T2722R. All of these residues are evolutionarily conserved, and either in direct contact with DSS1 (R2659 and G2748), or adjacent to DSS1 contacts (W2626, I2627, E2663, T2722, and D2723) in the BRCA2 DBD/DSS1/ssDNA structure (<a href="#B33" class="usa-link" aria-describedby="B33">33</a>). In particular, D2723 is involved in hydrogen bonding with other residues in OB1 (S2670, I2672 and W2725), to stabilize the HD / OB1 interface (<a href="#B33" class="usa-link" aria-describedby="B33">33</a>,<a href="#B45" class="usa-link" aria-describedby="B45">45</a>). Our observations therefore provide direct evidence that residues in the DBD affected by these pathogenic mutations are important for DSS1 binding.</p>
<p>By contrast, however, the pathogenic R3052W mutant, which is located at the OB2/ OB3 junction outside the DSS1-binding region of the DBD, engaged Myc-DSS1 just as effectively as the WT or benign mutant forms (Figure <a href="#F2" class="usa-link">2B</a> and <a href="#F2" class="usa-link">C</a>). Thus, the pathogenicity of the mutant may not be related to the loss of DSS1 binding.</p></section><section id="SEC3-3"><h3 class="pmc_sec_title">Pathogenic BRCA2 mutations in the DBD affect nuclear localization</h3>
<p>Whereas WT BRCA2 is normally localized primarily in the cell nucleus, mutant BRCA2 carrying the pathogenic mutation D2723H affecting Asp<sup>2723</sup> has previously been reported to be mis-localized to the cytosol (<a href="#B46" class="usa-link" aria-describedby="B46">46</a>,<a href="#B47" class="usa-link" aria-describedby="B47">47</a>). Moreover, we have previously shown that the cytoplasmic mis-localization of BRCA2<sup>D2723H</sup> is accompanied by the loss of DSS1 binding (<a href="#B36" class="usa-link" aria-describedby="B36">36</a>). Accordingly, we tested the subcellular localization of WT or mutant forms of GFP-BRCA2<sup>CT</sup> by expressing them in HeLa cells and measuring nuclear / cytoplasmic ratio of GFP intensity from the microscopic images (Figure <a href="#F2" class="usa-link">2D</a> and <a href="#F2" class="usa-link">E</a>).</p>
<p>Like WT GFP-BRCA2<sup>CT</sup>, the benign mutants T2515I and K2729N were primarily nuclear localized (nuclear / cytoplasmic ratio &gt;3). In contrast, all forms of GFP-BRCA2<sup>CT</sup> bearing pathogenic mutations localized primarily to the cytosol (nuclear / cytoplasmic ratio ≤1). Reduced nuclear localization was particularly marked in the D2723H mutant, whereas three other pathogenic mutants showed statistically significant higher ratios of nuclear / cytoplasmic localization compared to D2723H (Kruskal-Wallis test followed by Dunn's multiple comparison Test, W2626C: *, G2748D: ***, R3052W: ***). Interestingly, even those mutants with substantial Myc-DSS1-binding activity (W2626C, E2663V and G2748D; Figure <a href="#F2" class="usa-link">2B</a> and <a href="#F2" class="usa-link">C</a>) showed significantly reduced nuclear localization. Thus, our results suggest that even a small reduction in DSS1 binding significantly impairs the nuclear localization of cancer-causing <em>BRCA2</em> mutants within the DSS1-binding region of the DBD.</p>
<p>On the other hand, the pathogenic R3052W mutant, located outside the DSS1-binding region of the DBD, also showed significantly reduced nuclear localization despite having similar DSS1 binding activity to that of the WT form (Figure <a href="#F2" class="usa-link">2B</a> and <a href="#F2" class="usa-link">C</a>). Again, this result suggests that the pathogenicity of this mutant is unrelated to its DSS1-binding capacity.</p></section><section id="SEC3-4"><h3 class="pmc_sec_title">Computational modelling of mutant BRCA2 DBD folding</h3>
<p>Calculation of the change in chemical energy of a protein structure upon mutation (Gibbs free energy, ΔΔG) can be used to predict the influence of a mutation on the folded state of the protein (<a href="#B48" class="usa-link" aria-describedby="B48">48</a>,<a href="#B49" class="usa-link" aria-describedby="B49">49</a>). ΔΔG of a high enough energy provides evidence for an unfolding of the protein or protein surface, leading to mutational inactivation or improper protein trafficking and expression, especially if the mutation is buried within the protein structure.</p>
<p>To investigate the effect of BRCA2 DBD mutations on protein folding, we computationally modelled their consequences upon incorporation into the three available crystal structures (PDB reference 1MIU, 1MJE, 1IYJ) of rodent Brca2 DBD/Dss1 complexes (<a href="#B33" class="usa-link" aria-describedby="B33">33</a>). We exclusively studied pathogenic mutations affecting evolutionarily conserved residues (W2626C, I2627F, R2659T, E2663V, T2722R, D2723H, D2723G, G2748D and R3052W), since the amino acid sequence of rodent Brca2 DBD is 56% homologous to the human. We compared them to benign variants (K2729N, R2842H, R2888C, V2969M, R2973C, V3079I, D3170G) also affecting conserved amino acids. Our analyses (see Materials and Methods) point to two major effects that distinguish pathogenic DBD mutations from benign variants.</p>
<p>First, we calculated the change in Gibbs free energy (ΔΔ<em>G</em>) (<a href="#B50" class="usa-link" aria-describedby="B50">50</a>,<a href="#B51" class="usa-link" aria-describedby="B51">51</a>) upon mutation in all three crystal structures. A positive ΔΔG marks a destabilizing mutation, with a ΔΔ<em>G</em> ≥2.5 kcal/mol considered highly likely to destabilize the protein structure (<a href="#B49" class="usa-link" aria-describedby="B49">49</a>,<a href="#B52" class="usa-link" aria-describedby="B52">52</a>,<a href="#B53" class="usa-link" aria-describedby="B53">53</a>). We infer from these analyses that the D2723H mutation induces a positive ΔΔ<em>G</em> ≥10 kcal/mol in all three crystal structures (<a href="#sup1" class="usa-link">Supplementary Figure S1A</a>), predicting that it destabilizes DBD folding. In addition, six other pathogenic mutations (W2626C, I2627F, T2722R, D2723G, G2748G and R3052W) are predicted to induce a ΔΔ<em>G</em> ≥2.5 kcal/mol in at least two of the three crystal structures, suggesting that they also destabilize DBD folding.</p>
<p>A second analysis provides additional evidence for the effects of pathogenic DBD mutations on protein folding. Relative solvent accessibility (RSA) (<a href="#B54" class="usa-link" aria-describedby="B54">54</a>) measures how buried an amino acid is relative to its sidechain surface area, with residues that are completely buried (defined as those with an RSA ≤0.2) more likely to destabilize protein structure and cause unfolding (<a href="#B55" class="usa-link" aria-describedby="B55">55</a>). All pathogenic mutations are found to be completely buried within the protein structure, and whilst the benign mutations show a range of RSA values, the most buried benign mutations (V2969M and V3079I) show stabilizing or negligible changes in ΔΔ<em>G</em>.</p>
<p>The rank order of calculated changes in ΔΔG or RSA were not directly correlated with the pathogenicity of BRCA2 DBD mutants. For example, the pathogenic mutant R2659T exhibits only a modest ΔΔG, whereas the benign R2842H mutant exhibits a higher ΔΔG than certain pathogenic mutants (<a href="#sup1" class="usa-link">Supplementary Figure S1A</a>). However, when comparing the average ΔΔ<em>G</em> and RSA of the mutants across all structures studied, we find that pathogenic and benign mutations are significantly different (independent <em>t</em>-test <em>P</em> &lt; 0.001 in both cases) (<a href="#sup1" class="usa-link">Supplementary Figure S1B</a>), with pathogenic mutations exhibiting significantly higher average energy of mutation, and lower RSA. These findings are similar to those in a recent study of NOTCH1 and TP53 mutation selection in human skin (<a href="#B53" class="usa-link" aria-describedby="B53">53</a>). Taken together, our findings raise the possibility that pathogenic DBD mutants impair BRCA2 function by affecting protein folding.</p></section><section id="SEC3-5"><h3 class="pmc_sec_title">The BRCA2–DSS1 interaction antagonizes intracellular BRCA2 oligomerization</h3>
<p>Brh2, the BRCA2 ortholog in the fungus <em>Ustilago maydis</em>, has been shown to self-associate through its DSS1-binding domain to form oligomers, the dissociation of which via DSS1 interaction has been suggested as a regulatory mechanism for Brh2 function (<a href="#B56" class="usa-link" aria-describedby="B56">56</a>). To investigate whether human BRCA2 is regulated in a similar way, we first tested whether human BRCA2 self-interacts via the carboxyl-terminal DSS-binding regions encoded in the BRCA2<sup>CT</sup> fragment spanning residues 2432–3418.</p>
<p>To this end, we co-expressed in 293T cells BRCA2<sup>CT</sup> fragments tagged either with GFP (GFP-BRCA2<sup>CT</sup>) or mCherry (mCherry-BRCA2<sup>CT</sup>). Both WT and D2723H mutant forms of GFP-BRCA2<sup>CT</sup> pulled-down their mCherry tagged counterparts (Figure <a href="#F3" class="usa-link">3A</a>, mCherry western). Moreover, both WT and D2723H GFP-BRCA2<sup>CT</sup> fragments interact with endogenous BRCA2 protein in transfected cells (Figure <a href="#F3" class="usa-link">3A</a>, lower panel, BRCA2 western). Notably, an interaction between the BRCA2 N-terminal (1–714) and C-terminal (2300–3418) regions, which is also disrupted by DSS1, has been recently detected in an <em>in vitro</em> analysis using purified protein fragments (<a href="#B57" class="usa-link" aria-describedby="B57">57</a>).</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8191791_gkab308fig3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8191791/1069c1f19755/gkab308fig3.jpg" loading="lazy" height="766" width="757" alt="Figure 3."></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The BRCA2-DSS1 interaction antagonizes intracellular BRCA2 oligomerization. (<strong>A</strong>) Self-oligomerization of BRCA2<sup>CT</sup> is suppressed by Myc-DSS1. Wildtype or D2723H mutant forms of BRCA2<sup>CT</sup>, tagged with either GFP or mCherry, were transiently expressed in 293T cells with or without Myc-DSS1. Interaction was detected by anti GFP-IP and western blotting for mCherry-BRCA2<sup>CT</sup> and endogenous BRCA2. (<strong>B</strong>) Self-oligomerization of BRCA2<sup>CT</sup> fragments in the BRCA2 Knock-out (KO) HeLa cells. BRCA2<sup>CT</sup> fragments tagged with either GFP or mCherry were co-expressed in BRCA2 KO HeLa cells. Their interaction was detected by anti GFP-IP and western blotting for mCherry-BRCA2<sup>CT</sup>. GFP vector alone serves as a negative control. (<strong>C</strong>) GST-pull down assay. Purified GST-BRCA2<sup>CT</sup> fragments bound to the Glutathione Sepharose 4B beads were incubated with purified GFP-BRCA2<sup>CT</sup> fragments. The beads were washed, and bound proteins were eluted, before separation by SDS-PAGE. Interactions were detected by western blotting for GFP-BRCA2<sup>CT</sup>. GST alone serves as a negative control. (<strong>D</strong>) Native gel electrophoresis of GFP-BRCA2<sup>CT</sup>. Extracts from HeLa cells transiently expressing GFP-BRCA2<sup>CT</sup> forms with or without Myc-DSS1 were analysed by native gel electrophoresis. The bands corresponding to GFP-BRCA2<sup>CT</sup> oligomers, GFP-BRCA2<sup>CT</sup>/Myc-DSS1 complex and GFP-BRCA2<sup>CT</sup> are marked with arrows.</p></figcaption></figure><p>We therefore sought to test whether the observed self-interaction between the BRCA2<sup>CT</sup> fragments might be bridged via an N-terminal-to-C-terminal interaction with the full-length endogenous BRCA2 protein. To this end, we generated a <em>BRCA2</em> knock-out HeLa cell line (BRCA2 KO, <a href="#sup1" class="usa-link">Supplementary Figure S2A</a>) by CRISPR/Cas9 gene editing, and then co-expressed GFP-BRCA2<sup>CT</sup> and mCherry-BRCA2<sup>CT</sup> in this cell line. Despite the absence of full-length endogenous BRCA2 protein, GFP-BRCA2<sup>CT</sup> retains its interaction with mCherry-BRCA2<sup>CT</sup> (Figure <a href="#F3" class="usa-link">3B</a>). These findings suggest that the observed self-interaction between the BRCA2<sup>CT</sup> fragments is not bridged by the endogenous BRCA2 protein. We further corroborated this result by testing whether there was an interaction between BRCA2<sup>CT</sup> fragments tagged either with GST (GST-BRCA2<sup>CT</sup>) or GFP (GFP-BRCA2<sup>CT</sup>) purified from <em>E. coli</em> (<a href="#sup1" class="usa-link">Supplementary Figure S2B</a>). Both WT and D2723H mutant forms of purified GST-BRCA2<sup>CT</sup> fragments exhibited an interaction with their cognate GFP-tagged forms (Figure <a href="#F3" class="usa-link">3C</a>). Collectively, our findings suggest that the self-interaction we observe between BRCA2<sup>CT</sup> fragments is direct, and distinct from the BRCA2 N-terminal-to-C-terminal interaction that was reported recently (<a href="#B57" class="usa-link" aria-describedby="B57">57</a>).</p>
<p>Interestingly, expression of Myc-DSS1 disrupts the interaction between GFP- and mCherry-tagged WT BRCA2<sup>CT</sup> fragments, but not the interaction between GFP- and mCherry-tagged D2723H mutant BRCA2<sup>CT</sup> fragments (Figure <a href="#F3" class="usa-link">3A</a>, mCherry western). The interaction of endogenous BRCA2 with WT GFP-BRCA2<sup>CT</sup> is also disrupted by Myc-DSS1, but not its interaction with D2723H mutant GFP-BRCA2<sup>CT</sup> (Figure <a href="#F3" class="usa-link">3A</a>, lower panel, BRCA2 western). These results suggest firstly, that wildtype BRCA2 can self-interact via the carboxyl-terminal DSS1-binding regions encoded in the BRCA2<sup>CT</sup> fragment spanning residues 2432–3418, and that this interaction is suppressed by DSS1 binding. Second, they suggest that the D2723H mutation, which markedly suppresses DSS1 binding, leads to persistent self-oligomerization that is refractory to DSS1 expression.</p>
<p>These conclusions are further supported by evidence from native gel electrophoresis of intracellular forms of wildtype versus mutant GFP-BRCA2<sup>CT</sup> fragments expressed, when Western blotted with anti-GFP. In cell extracts, wildtype GFP-BRCA2<sup>CT</sup> migrates in two forms – first, a faster-migrating species consistent with a monomeric form, and second, as a smear of species with retarded gel mobility that may represent oligomeric forms. Co-expression of Myc-DSS1 alters this pattern. The smear of slow-migrating forms of GFP-BRCA2<sup>CT</sup> is focused into one prominent band, which migrates more slowly than the band corresponding to a GFP-BRCA2<sup>CT</sup> monomer (Figure <a href="#F3" class="usa-link">3D</a>, left panel). Western blotting with anti-Myc antibodies shows that the faster-migrating of these two bands does not contain Myc-DSS1 (Figure <a href="#F3" class="usa-link">3D</a>, right panel), suggesting that it represents monomeric GFP-BRCA2<sup>CT</sup> alone or in complex with other proteins. By contrast, the slower-migrating band (Figure <a href="#F3" class="usa-link">3D</a>, right panel) contains Myc-DSS1, consistent with a monomeric Myc-DSS1/GFP-BRCA2<sup>CT</sup> complex.</p>
<p>Myc-DSS1 expression has varied effects on the native gel mobility of two different mutant GFP-BRCA2<sup>CT</sup> fragments. The W2626C mutant (which retains residual DSS1 binding activity (Figure <a href="#F2" class="usa-link">2B</a> and <a href="#F2" class="usa-link">C</a>)) migrates predominantly as apparent oligomers. Like the wildtype GFP-BRCA2<sup>CT</sup> protein, Myc-DSS1 co-expression focuses the W2626C mutant into one band consistent with a monomeric GFP-BRCA2<sup>CT</sup> W2626C / Myc-DSS1 complex (besides a second band consistent with monomeric GFP-BRCA2<sup>CT</sup> W2626C alone or in complex with other proteins) as described above (Figure <a href="#F3" class="usa-link">3D</a>). In contrast, the D2723H mutant (which is devoid of detectable DSS1 binding activity) persistently migrates as apparent oligomers even when co-expressed with Myc-DSS1 (Figure <a href="#F3" class="usa-link">3D</a>).</p>
<p>Thus, these results suggest that mutant BRCA2<sup>CT</sup> expressed in cells form self-oligomers to a greater extent than wildtype forms. Overexpressed DSS1 antagonizes oligomer formation by wildtype BRCA2<sup>CT</sup>, or its pathogenic W2626C mutant which retains residual DSS1-binding activity, but not the D2723H mutant form.</p></section><section id="SEC3-6"><h3 class="pmc_sec_title">Pathogenic DBD mutants introduced into the endogenous <em>BRCA2</em> gene cause cytosolic mis-localization and disable DNA repair by HDR</h3>
<p>We used two pathogenic BRCA2 DBD mutants—W2626C and D2723H, affecting the HD and OB1-fold respectively—to exemplify effects on the function of BRCA2 in HDR. To this end, we used CRISPR/Cas9 gene editing to generate HeLa Kyoto cells bearing homozygous full-length forms of each of these BRCA2 mutations (BRCA2<sup>W2626C/W2626C</sup> or BRCA2<sup>D2723H/ D2723H</sup>; hereafter called HeLa-W2626C or HeLa-D2723H). Two homozygous clones for each mutation validated by nucleotide sequencing were used for further studies.</p>
<p>We first tested the intracellular localization of the BRCA2<sup>W2626C</sup> and BRCA2<sup>D2723H</sup> mutants by fractionation into nuclear and cytosolic fractions, which were analysed by western blotting. Consistent with our results for the GFP-BRCA2<sup>CT</sup> fragments, both BRCA2<sup>W2626C</sup> and BRCA2<sup>D2723H</sup> mutants localized primarily in the cytosol, as was RAD51, suggesting that mutant BRCA2/RAD51 complexes were mis-localized in the mutant cell lines (Figure <a href="#F4" class="usa-link">4A</a>).</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8191791/6a00629edd20/gkab308fig4.jpg" loading="lazy" height="726" width="719" alt="Figure 4."></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Pathogenic DBD mutants introduced into the endogenous <em>BRCA2</em> gene cause cytosolic mis-localization and disable DNA repair by HDR. (<strong>A</strong>) Subcellular fractionation of <em>BRCA2</em> mutant cell lines, HeLa-W2626C and HeLa-D2723H. Two independent clones for each mutation were used. Nuclear and cytoplasmic fractions of BRCA2 and RAD51 were analysed by western blotting. MEK2 is a cytoplasmic marker. (<strong>B</strong>) mClover Lamin A HDR assay. Cells transfected with Lamin A-targeting sgRNA and mClover Lamin A donor constructs as shown in the schematic were analysed for mClover Lamin A-positive cells. Mean of HDR positive cells (%) ± s.e. from two repeats is shown. More than 100 cells per sample were analysed in each repeat. Statistical significance was tested by one-way ANOVA test, followed by Bonferroni's multiple comparison test.</p></figcaption></figure><p>Next, we measured the proficiency of HeLa-W2626C or HeLa-D2723H in carrying out HDR using the mClover Lamin A assay (<a href="#B40" class="usa-link" aria-describedby="B40">40</a>,<a href="#B41" class="usa-link" aria-describedby="B41">41</a>). Cells were transfected with the construct expressing Cas9/<em>Lamin A</em> targeting sgRNA and the donor construct consisting of mClover sequence flanked by <em>Lamin A</em> homology arms. Three days after transfection, cells were fixed and analysed by microscopy. Close to 40% of WT cells were mClover Lamin A positive reflecting faithful incorporation of mClover sequence into <em>Lamin A</em> gene by HDR. In contrast, both mutants showed very low HR efficiency (Figure <a href="#F4" class="usa-link">4B</a> and <a href="#sup1" class="usa-link">Supplementary Figure S3</a>).</p>
<p>Thus, we show using two different DBD mutants introduced into the endogenous <em>BRCA2</em> gene by CRISPR/Cas9 mutagenesis that the disruption of DSS1 binding causes cytosolic mis-localization of the encoded BRCA2 proteins, and disables DNA repair by HDR. Interestingly, the W2626C or D2723H mutations affect BRCA2 localization and impair HDR to similar degrees, even though the BRCA2 W2626C mutant retains residual DSS1-binding capacity whereas the D2723H mutant does not. Our observations speak to the importance of DSS1 engagement for the transport of BRCA2 to its sites of activity in the cell nucleus.</p></section><section id="SEC3-7"><h3 class="pmc_sec_title">Pathogenic DBD mutants exhibit defective nuclear import</h3>
<p>To investigate what causes pathogenic BRCA2 DBD mutants to mis-localize in the cytosol, we employed a photoactivable GFP (paGFP) assay (<a href="#B58" class="usa-link" aria-describedby="B58">58</a>,<a href="#B59" class="usa-link" aria-describedby="B59">59</a>) to test their nuclear import. We expressed paGFP-tagged wildtype or mutant BRCA2<sup>CT</sup> fragments in HeLa Kyoto cells, before photoactivating a defined cytoplasmic region using a 405 nm laser. The migration of photoactivated species from the cytosol to the nucleus was then monitored over a 3-minute period (Figure <a href="#F5" class="usa-link">5A</a>, experimental scheme).</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8191791_gkab308fig5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8191791/a3ee5926ea02/gkab308fig5.jpg" loading="lazy" height="977" width="693" alt="Figure 5."></a></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Pathogenic DBD mutants exhibit defective nuclear import. (<strong>A</strong>) Nuclear import assay using BRCA2<sup>CT</sup> tagged with photoactivable GFP (paGFP). HeLa cells expressing wildtype or mutant forms of paGFP-BRCA2<sup>CT</sup> were monitored by live imaging. As shown in the schematic, photoactivation of a cytosolic area (red square) was followed by measurement of fluorescence intensity in the designated area in the cytosol (red square) and the nucleus (blue square). Plots show the relative fluorescence intensity (mean ± s.e.), normalized to the maximum intensity in each cell. 8–10 cells per sample were analysed. Black arrows mark the timing of photoactivation. (<strong>B</strong>) HeLa cells expressing paGFP-BRCA2<sup>CT</sup> W2626C with or without Myc-DSS1 were monitored by live imaging after cytosolic photoactivation and analysed as shown in (A). (<strong>C</strong>) Efficiency of DSS1 depletion by siRNA transfection. Relative level of DSS1 mRNA measured by RT-qPCR assay, a result from technical triplicate is shown. Statistical significance was assessed by paired <em>t</em>-test. (<strong>D</strong> and <strong>E</strong>) Nucleocytoplasmic distribution of the GFP-BRCA2<sup>CT</sup> fragment after DSS1 depletion. HeLa cells were transfected with control or DSS1 siRNA 24 h before transfecting with the GFP-BRCA2<sup>CT</sup> construct. Nucleocytoplasmic distribution was analysed as described in Figure <a href="#F2" class="usa-link">2E</a>. The graph (E) shows the GFP intensity ratio (nuclear/cytoplasmic, mean ± s.e.). More than 100 cells per sample were analysed. Statistical significance was assessed by unpaired t-test. A representative result from three independent experiments is shown. Representative microscopic images are shown in (D). Scale bar, 10 μm. (<strong>F</strong>) Subcellular fractionation of HeLa cells after DSS1 depletion. HeLa cells were transfected with control or DSS1 siRNA 48 h before fractionation. Nuclear and cytoplasmic fractions of BRCA2 and RAD51 were analysed by western blotting. The nuclear/cytoplasmic ratio of BRCA2 expression is shown. MEK2 is a cytoplasmic marker. Total cell extracts are also shown. A representative result from two independent experiments is shown.</p></figcaption></figure><p>Wildtype paGFP-BRCA2<sup>CT</sup> exhibited low levels of cytosolic photoactivation, consistent with the predominantly nuclear localization of wildtype BRCA2. Photoactivated wildtype paGFP-BRCA2<sup>CT</sup> was rapidly transported into the cell nucleus, as indicated by a rapid increase in nuclear fluorescence. This nuclear fluorescence decreased over time due to diffusion within nucleus until equilibrium was reached at 1 min after photoactivation. At equilibrium, nuclear fluorescence was maintained at ∼30% of the initial peak, whereas cytosolic fluorescence was at basal levels, indicative of the efficient nuclear import of BRCA2<sup>CT</sup>.</p>
<p>In contrast to wildtype, the paGFP-BRCA2<sup>CT</sup> D2723H mutant exhibited a high level of cytosolic photoactivation consistent with its concentration in the cytosol. After photoactivation, there was no detectable increase in nuclear fluorescence (although cytosolic fluorescence intensity dissipated from the photoactivated region due to diffusion). When equilibrium was reached at 3 min, there was only a minimal increase in nuclear intensity, speaking to a defect in nuclear import (Figure <a href="#F5" class="usa-link">5A</a> and <a href="#sup1" class="usa-link">Supplementary Figure S4</a>). Collectively, these results suggest that the paGFP-BRCA2<sup>CT</sup> D2723H mutant protein is not efficiently transported to the nucleus.</p></section><section id="SEC3-8"><h3 class="pmc_sec_title">DSS1 expression restores the nuclear localization of pathogenic BRCA2 DBD mutants</h3>
<p>We find (Figure <a href="#F3" class="usa-link">3</a>) that both wildtype and mutant forms of the BRCA2<sup>CT</sup> protein form self-oligomers in cell extracts, and that DSS1 expression can antagonize oligomerization of the wildtype but not mutant forms. These observations prompted us to test whether DSS1 expression could also affect the nuclear localization of pathogenic BRCA2 DBD mutant proteins.</p>
<p>Accordingly, we co-expressed the wildtype or different mutant forms of GFP-BRCA2<sup>CT</sup> with Myc-DSS1, and compared their nuclear / cytoplasmic distribution by microscopy (Figure <a href="#F6" class="usa-link">6A</a> and <a href="#F6" class="usa-link">B</a>). Myc-DSS1 expression modestly increased the nuclear/cytoplasmic ratio of wildtype GFP-BRCA2<sup>CT</sup> by 1.7-fold. Myc-DSS1 expression had a similar effect on the distribution of the mutant proteins but to varying degrees. Whereas the nuclear / cytoplasmic ratio of W2626C and E2663V mutants increased by 3.5- to 5-fold, and that of the I2627F, R2659T and G2748D mutants by 1.8- to 2.4-fold, the T2722R, D2723H and D2723G mutants showed little change in nuclear localization. Thus, our findings collectively speak to the idea that DSS1 antagonizes the self-oligomerization of BRCA2 DBD to promote its nuclear localization.</p>
<figure class="fig xbox font-sm" id="F6"><h4 class="obj_head">Figure 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8191791_gkab308fig6.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8191791/bb70e3a1a020/gkab308fig6.jpg" loading="lazy" height="903" width="751" alt="Figure 6."></a></p>
<div class="p text-right font-secondary"><a href="figure/F6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>DSS1 expression restores the nuclear localization and HDR function of hypomorphic BRCA2 pathogenic mutants. (<strong>A</strong> and <strong>B</strong>) Nucleocytoplasmic distribution of the DBD mutants with DSS1 overexpression. HeLa cells expressing GFP-BRCA2<sup>CT</sup> forms without (vector only) or with Myc-DSS1 were fixed with PFA and analysed by microscopy. Representative images are shown. Scale bar, 10μm. The graph (B) shows GFP intensity ratio (nuclear/cytoplasmic, mean ± s.e.) measured from the images. Myc-DSS1 expression increases the nuclear/cytoplasmic ratio of GFP-BRCA2<sup>CT</sup> fragments to varying degrees: WT by 1.7 fold; W2626C and E2663V mutants by 3.5- to 5-fold; I2627F, R2659T, and G2748D mutants by 1.8- to 2.4-fold; T2722R, D2723H, and D2723G mutants, little change. More than 100 cells per sample were analysed. Statistical significance was assessed by one-way ANOVA test, followed by Bonferroni's multiple comparison test. A representative result from three independent experiments is shown. (<strong>C</strong>) mClover Lamin A HDR assay. HeLa cells harbouring BRCA2 mutations (Figure <a href="#F4" class="usa-link">4</a>) were transfected with vector or Myc-DSS1 plasmids in addition to mClover Lamin A HDR assay plasmids. Mean of HDR positive cells (%) ± s.e. from two repeats is shown. More than 100 cells per sample were analysed in each repeat. Statistical significance was assessed by one-way ANOVA test, followed by Bonferroni's multiple comparison test.</p></figcaption></figure><p>Notably, the rank order in which DSS1 expression restored the nuclear localization of different BRCA2 DBD mutant proteins was similar to the rank order of DSS1 binding by the mutant proteins (Figure <a href="#F2" class="usa-link">2C</a>), but did not follow a simple linear relationship. Nevertheless, the nuclear localization of mutants that retain residual DSS1-binding was corrected by DSS1 overexpression, whereas the D2723H and D2723G mutants which severely lack DSS1 binding was not. One possibility raised by these findings is that a critical threshold of DSS1 binding may be required for BRCA2 transport and function.</p>
<p>To further substantiate and extend this conclusion, we also tested the effect of Myc-DSS1 expression on the nuclear import of the paGFP-BRCA2<sup>CT</sup> W2626C mutant protein using the paGFP assay. The GFP-BRCA2<sup>CT</sup> W2626C mutant exhibits reduced but not absent DSS1 binding (Figure <a href="#F2" class="usa-link">2C</a>), and its oligomerization can be suppressed by Myc-DSS1 expression (Figure <a href="#F3" class="usa-link">3D</a>). The nuclear import of the paGFP-BRCA2<sup>CT</sup> W2626C mutant was impaired to a similar degree (Figure <a href="#F5" class="usa-link">5B</a>, left panel) as the D2723H mutant. Strikingly, Myc-DSS1 co-expression markedly increases the nuclear import of paGFP-BRCA2<sup>CT</sup> W2626C (Figure <a href="#F5" class="usa-link">5B</a>, right panel), restoring it to a level akin to the wildtype paGFP-BRCA2<sup>CT</sup> protein.</p>
<p>We find that over-expressed DSS1, but not its endogenous levels, can restore the nuclear localization of certain mutant forms of BRCA2. This finding raises the possibility that endogenous DSS1 is rate-limiting for BRCA2 nuclear transport. Accordingly, we depleted DSS1 from HeLa cells by siRNA transfection (Figure <a href="#F5" class="usa-link">5C</a>) before expressing GFP-BRCA2<sup>CT</sup>. The nucleocytoplasmic ratio of GFP-BRCA2<sup>CT</sup> was significantly decreased to an extent similar to that of the mutant forms (Figure <a href="#F5" class="usa-link">5D</a> and <a href="#F5" class="usa-link">E</a>). Notably, subcellular fractionation followed by western blotting also shows that DSS1 depletion in HeLa cells reduces the nuclear localization of full-length endogenous BRCA2 (Figure <a href="#F5" class="usa-link">5F</a>). We note that total level of BRCA2 decreases after DSS1 depletion, consistent with a previous report (<a href="#B35" class="usa-link" aria-describedby="B35">35</a>). These results together provide further lines of evidence that DSS1 binding by the BRCA2 DBD is essential for the nuclear localization of BRCA2.</p>
<p>Interestingly, we find that the GFP-BRCA2<sup>CT</sup> R3052W mutant (which retains its DSS1-binding ability (Figure <a href="#F2" class="usa-link">2C</a>)) is also mis-localized to the cytosol, and that its nuclear localization is increased by 1.9-fold through Myc-DSS1 expression (Figure <a href="#F6" class="usa-link">6B</a>). The R3052W mutation is predicted to disrupt a hydrogen bonding network that supports an interaction between OB2 and OB3 domains, outside DSS1 interaction sites (<a href="#B45" class="usa-link" aria-describedby="B45">45</a>,<a href="#B46" class="usa-link" aria-describedby="B46">46</a>), and therefore probably affects BRCA2 DBD folding. In addition, the nuclear localization of GFP-BRCA2<sup>CT</sup> wildtype protein is also slightly increased by Myc-DSS1, consistent with our observation that wildtype GFP-BRCA2<sup>CT</sup> protein exhibits a small degree of self-oligomerization antagonized by DSS1 (Figure <a href="#F3" class="usa-link">3D</a>).</p>
<p>Thus, when considered together, our findings provide multiple lines of evidence to support a model wherein the regulated assembly of BRCA2/DSS1 monomers from BRCA2 oligomers assists in the normal folding, assembly and nuclear transport of BRCA2. Cancer-causing mutations in the DBD, either by diminishing DSS1 binding and/or by affecting DBD folding, perturb this intracellular assembly mechanism to impair nuclear localization. Notably, effects on DBD folding may in turn also impair the DNA binding ability of these mutants.</p></section><section id="SEC3-9"><h3 class="pmc_sec_title">Expression of DSS1 restores HDR in cells bearing hypomorphic BRCA2 pathogenic mutants</h3>
<p>Our observation that increased DSS1 expression enhances the nuclear localization of BRCA2 DBD mutant proteins prompted us to test for the restoration of DNA repair by HDR. To this end, we used the mutant cell lines HeLa-W2626C or HeLa-D2723H (Figure <a href="#F4" class="usa-link">4</a>), in which CRISPR/Cas9 engineering was used to introduce either the W2626C or D2723H mutation into both endogenous alleles of <em>BRCA2</em>. Myc-DSS1 expression in HeLa-W2626C significantly increased HDR measured by the mClover Lamin A assay, by 6-fold from 3% to 18% (roughly half the level of wildtype cells). By contrast, Myc-DSS1 expression did not significantly affect HDR in HeLa-D2723H cells (Figure <a href="#F6" class="usa-link">6C</a>). Thus, the HDR defect in cells bearing the pathogenic W2626C mutation in <em>BRCA2</em> – a hypomorphic variant that exhibits reduced but not absent DSS1 binding - can be corrected by DSS1 expression. However, cells carrying the pathogenic D2723H mutant devoid of detectable DSS1 binding could not be corrected in this way. Together, these results provide further evidence that cancer-causing BRCA2 missense mutations disrupt a DSS1-mediated intracellular protein assembly mechanism essential for its function in DNA repair by HDR, and suggest an approach for therapeutic correction via drugs that mimic the effects of DSS1 binding.</p></section></section><section id="SEC4"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p>We identify here a common mechanism underlying the pathogenicity of 9 out of 13 missense mutations in human BRCA2 classified as cancer-causing by expert panel review from amongst 37 known mis-sense mutations. The mutations we have analysed cluster in the short, ∼340 residue DBD of human BRCA2, which represents only ∼10% of the 3418 residue BRCA2 protein. Four additional missense mutations also affect conserved residues in the same short BRCA2 segment, and may therefore act by a similar mechanism, although their pathogenicity was confirmed by expert panel review only recently (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>) during the completion of the studies reported here. We show that each of the pathogenic mutations we have analysed mis-localizes BRCA2 to the cytosol, extending previously reported findings that the D2723H DBD mutation acts so (<a href="#B36" class="usa-link" aria-describedby="B36">36</a>,<a href="#B46" class="usa-link" aria-describedby="B46">46</a>,<a href="#B47" class="usa-link" aria-describedby="B47">47</a>). We demonstrate that pathogenic mis-sense mutations in the HD, OB1 or OB2 regions of the DBD inhibit, to varying degrees, DSS1 binding by BRCA2. Moreover, we provide evidence that the introduction into endogenous <em>BRCA2</em> of mis-sense mutations that either retain residual DSS1-binding capacity (the W2626C mutant), or ablate it more severely (the D2723H mutant) have similar effects in impairing the nuclear localization of full-length BRCA2 protein, as well as its essential function in DNA repair by HDR. Our results have important implications not only because inherited mutations affecting <em>BRCA2</em> are amongst the commonest causes of human cancer susceptibility, but also because deciphering their effects on BRCA2 function is essential to assess cancer risk, and devise new approaches for treatment or prevention.</p>
<p>We provide evidence that intracellular BRCA2 undergoes self-oligomerisation that is regulated by DSS1, reminiscent of elegant genetic studies in <em>U. maydis</em> that first identified such a process affecting the orthologous protein, Brh2 (<a href="#B56" class="usa-link" aria-describedby="B56">56</a>). Our results extend and complement recently reported <em>in vitro</em> biochemical studies which show that purified BRCA2 protein self-associates via amino (N)- carboxyl (C) terminal and N-N terminal interactions, and that the N-C terminal self-interaction is sensitive to inhibition by DSS1 and single-stranded (ss)DNA (<a href="#B57" class="usa-link" aria-describedby="B57">57</a>). We provide here evidence that self-interaction can also directly occur between the C-terminal regions of BRCA2, and that this C-C terminal interaction contributes to the intracellular oligomerization of BRCA2 in a manner that can be antagonized by DSS1 overexpression. Interestingly, we find that the intracellular oligomerization and cytosolic mis-localization of pathogenic BRCA2 DBD mutations that diminish but do not ablate DSS1 binding is suppressed by DSS1 overexpression, whereas the oligomerization of DBD mutants devoid of detectable DSS1 binding is unaffected. Thus, our studies suggest that the disruption of DSS1-regulated BRCA2 assembly and nuclear transport underlies the pathogenicity of cancer-causing mutations affecting the DBD.</p>
<p>However, the mechanisms by which DSS1 regulates BRCA2 function via its interaction with the DBD are likely to be complex, because pathogenic BRCA2 DBD mutations consistently impair the intracellular assembly and nuclear localization of BRCA2 in a manner that is not directly related to their DSS1-binding capacity. For example, the W2626C mutant (which retains significant DSS1 binding) forms intracellular oligomers and is as impaired in its nuclear localization and loss of HDR function as the D2723H mutant (which lacks detectable DSS1 binding). These findings suggest that even small decreases in DSS1 binding capacity may impair BRCA2 transport and function, again speaking to the possibility that there is a critical threshold of DSS1 binding below which mutant BRCA2 molecules are rendered defective.</p>
<p>Taken together, these findings suggest a hypothetical model (Figure <a href="#F7" class="usa-link">7</a>) wherein DSS1 regulates the intracellular oligomerization of BRCA2 in a protein assembly mechanism that is essential for nuclear transport, consistent with its proposed activity as a chaperone that assists the folding and intracellular trafficking of multi-protein complexes (<a href="#B60" class="usa-link" aria-describedby="B60">60</a>). Indeed, we show here using photoactivation and dynamic fluorescence imaging that defects in nuclear transport contribute to the mis-localization of multiple pathogenic BRCA2 DBD mutants, beyond the effects of DSS1 binding on nuclear export of the D2723H mutant that we previously reported (<a href="#B36" class="usa-link" aria-describedby="B36">36</a>). However, pathogenic BRCA2 mis-sense mutations in the DBD exhibit apparently stereotypic defects in nuclear localization regardless of the degree of defective DSS1-binding. Conversely, BRCA2 D2723H, the pathogenic DBD mutant with the most severe lack of DSS1 binding activity, is still transported to the nucleus albeit in reduced amounts. We therefore suggest that defects in folding, nuclear transport and nuclear export induced by loss of DSS1 binding may collectively contribute to the observed phenotypic defects.</p>
<figure class="fig xbox font-sm" id="F7"><h3 class="obj_head">Figure 7.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95b/8191791/a982d4089c5f/gkab308fig7.jpg" loading="lazy" height="384" width="708" alt="Figure 7."></p>
<div class="p text-right font-secondary"><a href="figure/F7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance. Our results suggest a hypothetical model wherein the engagement of DSS1 by the DBD of BRCA2 antagonizes BRCA2 self-oligomerization and promotes protein folding. Assembly of a correctly folded BRCA2/DSS1 complex enables nuclear transport. Cancer-causing mutations in the BRCA2 DBD impair DSS1 binding, perturbing this protein assembly mechanism, and provoking the formation of intracellular BRCA2 oligomers that are excluded from the cell nucleus. The failure to assemble correctly folded mutant BRCA2/DSS1 complexes, and cytosolic mis-localization of the mutant BRCA2, disables HDR in cells harbouring the DBD mutations. DSS1 can antagonize the self-oligomerization of wild-type BRCA2, and of cancer-causing DBD mutants such as W2626C that retain some degree of DSS1 binding.</p></figcaption></figure><p>That the localization and function of BRCA2, a large protein essential for genome integrity in dividing human cells, should depend so critically on its interaction with the 70 amino acid DSS1 polypeptide is difficult to reconcile with the robustness typical of biological systems. However, even BRCA2 D2723H, which lacks detectable DSS1 binding, localizes to the nucleus at least in small amounts sufficient for cell viability and growth. Moreover, even the low concentrations at which endogenously tagged BRCA2 protein (eg., (<a href="#B61" class="usa-link" aria-describedby="B61">61</a>,<a href="#B62" class="usa-link" aria-describedby="B62">62</a>)) is expressed do not appear to be rate-limiting for genome stability in wild-type cells. We speculate that these features may have precluded the selection during evolution of more robust mechanisms for BRCA2 protein folding and intracellular trafficking.</p>
<p>Notably, we find that the impaired nuclear localization and DNA repair function of certain pathogenic BRCA2 DBD mutants that retain DSS1 binding capacity, like W2626C, can be ameliorated by DSS1 overexpression. Since DSS1 encodes a short, 70 residue polypeptide whose binding sites within the BRCA2 DBD have been structurally characterized (<a href="#B33" class="usa-link" aria-describedby="B33">33</a>), our results suggest that peptidomimetic agents which engage the DSS1-binding site in certain mutant forms of BRCA2 could correct the functional defect. Thus, our work opens opportunities for cancer prevention in patients who carry particular <em>BRCA2</em> missense mutations.</p></section><section id="sec29"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="sup1"><div class="caption p"><span>gkab308_Supplemental_File</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8191791/bin/gkab308_supplemental_file.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (844.5KB, pdf) </sup>
</div></div></section></section><section id="ACK1" class="ack"><h2 class="pmc_sec_title">ACKNOWLEDGEMENTS</h2>
<p>We thank members of A.R.V.’s laboratory for helpful comments and discussion.</p>
<p>
<em>Author contributions</em>: A.R.V. and M.L. conceived the project and designed the experiments. M.L. performed the experiments. R.M. contributed to the paGFP nuclear import assay. M.L. analysed the results with A.R.V. D.S. performed the ΔΔG/RSA analysis under B.A.H.’s supervision. A.R.V. wrote the manuscript with M.L.</p></section><section id="NT1"><h2 class="pmc_sec_title">Notes</h2>
<p>Present address: David Shorthouse &amp; Benjamin A. Hall, Department of Medical Physics and Biomedical Engineering, Malet Place Engineering Building, University College London, Gower Street, London WC1E 6BT, UK.</p></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Miyoung Lee, 
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK.</p>
<p>David Shorthouse, 
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK.</p>
<p>Robert Mahen, 
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK.</p>
<p>Benjamin A Hall, 
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK.</p>
<p>Ashok R Venkitaraman, 
Medical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK; 
The Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599 &amp; Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove 138648, Singapore.</p></section><section id="SEC5"><h2 class="pmc_sec_title">SUPPLEMENTARY DATA</h2>
<p>
<a href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkab308#supplementary-data" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Supplementary Data</a> are available at NAR Online.</p></section><section id="SEC6"><h2 class="pmc_sec_title">FUNDING</h2>
<p>Medical Research Council (MRC) Programme grants [MC_UU_12022/1, MC_UU_12022/8 to A.R.V.]; MRC grant [MR/S000216/1] and Royal Society grant [UF130039] to B.A.H.; M.L. and R.M were supported by a Team Science Award to A.R.V. from the Gray Foundation, New York. Funding for open access charge: MRC Programme grants [MC_UU_12022/1, MC_UU_12022/8].</p>
<p>
<em>Conflict of interest statement</em>. None declared.</p></section><section id="REF1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="REF1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>
Antoniou A., Pharoah P.D.P., Narod S., Risch H.A., Eyfjord J.E., Hopper J.L., Loman N., Olsson H., Johannsson O., Borg Å.et al.. 
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 2003; 72:1117–1130.</cite> [<a href="https://doi.org/10.1086/375033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1180265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12677558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Average%20risks%20of%20breast%20and%20ovarian%20cancer%20associated%20with%20BRCA1%20or%20BRCA2%20mutations%20detected%20in%20case%20series%20unselected%20for%20family%20history:%20a%20combined%20analysis%20of%2022%20studies&amp;volume=72&amp;publication_year=2003&amp;pages=1117-1130&amp;pmid=12677558&amp;doi=10.1086/375033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>
Breast Cancer Linkage Consortium
Cancer risks in BRCA2 mutation carriers. J. Natl. Cancer Inst. 1999; 91:1310–1316.</cite> [<a href="https://doi.org/10.1093/jnci/91.15.1310" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10433620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=Cancer%20risks%20in%20BRCA2%20mutation%20carriers&amp;volume=91&amp;publication_year=1999&amp;pages=1310-1316&amp;pmid=10433620&amp;doi=10.1093/jnci/91.15.1310&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>
Nathanson K.N., Wooster R., Weber B.L.. 
Breast cancer genetics: what we know and what we need. Nat. Med. 2001; 7:552–556.</cite> [<a href="https://doi.org/10.1038/87876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11329055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&amp;title=Breast%20cancer%20genetics:%20what%20we%20know%20and%20what%20we%20need&amp;volume=7&amp;publication_year=2001&amp;pages=552-556&amp;pmid=11329055&amp;doi=10.1038/87876&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>
Rahman N., Stratton M.R.. 
The genetics of breast cancer susceptibility. Annu. Rev. Genet. 1998; 32:95–121.</cite> [<a href="https://doi.org/10.1146/annurev.genet.32.1.95" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9928476/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu.%20Rev.%20Genet.&amp;title=The%20genetics%20of%20breast%20cancer%20susceptibility&amp;volume=32&amp;publication_year=1998&amp;pages=95-121&amp;pmid=9928476&amp;doi=10.1146/annurev.genet.32.1.95&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>
Welcsh P.L., King M.-C.. 
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 2001; 10:705–713.</cite> [<a href="https://doi.org/10.1093/hmg/10.7.705" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11257103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mol.%20Genet.&amp;title=BRCA1%20and%20BRCA2%20and%20the%20genetics%20of%20breast%20and%20ovarian%20cancer&amp;volume=10&amp;publication_year=2001&amp;pages=705-713&amp;pmid=11257103&amp;doi=10.1093/hmg/10.7.705&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>
Lindor N.M., Guidugli L., Wang X., Vallée M.P., Monteiro A.N.A., Tavtigian S., Goldgar D.E., Couch F.J.. 
A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Hum. Mutat. 2012; 33:8–21.</cite> [<a href="https://doi.org/10.1002/humu.21627" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3242438/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21990134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=A%20review%20of%20a%20multifactorial%20probability-based%20model%20for%20classification%20of%20BRCA1%20and%20BRCA2%20variants%20of%20uncertain%20significance%20(VUS)&amp;volume=33&amp;publication_year=2012&amp;pages=8-21&amp;pmid=21990134&amp;doi=10.1002/humu.21627&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>
Spurdle A.B., Healey S., Devereau A., Hogervorst F.B.L., Monteiro A.N.A., Nathanson K.L., Radice P., Stoppa-Lyonnet D., Tavtigian S., Wappenschmidt B.et al.. 
ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum. Mutat. 2012; 33:2–7.</cite> [<a href="https://doi.org/10.1002/humu.21628" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3240687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21990146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=ENIGMA-Evidence-based%20network%20for%20the%20interpretation%20of%20germline%20mutant%20alleles:%20an%20international%20initiative%20to%20evaluate%20risk%20and%20clinical%20significance%20associated%20with%20sequence%20variation%20in%20BRCA1%20and%20BRCA2%20genes&amp;volume=33&amp;publication_year=2012&amp;pages=2-7&amp;pmid=21990146&amp;doi=10.1002/humu.21628&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>
Easton D.F., Deffenbaugh A.M., Pruss D., Frye C., Wenstrup R.J., Allen-Brady K., Tavtigian S.V., Monteiro A.N.A., Iversen E.S., Couch F.J.et al.. 
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer–predisposition genes. Am. J. Hum. Genet. 2007; 81:873–883.</cite> [<a href="https://doi.org/10.1086/521032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2265654/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17924331/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=A%20systematic%20genetic%20assessment%20of%201,433%20sequence%20variants%20of%20unknown%20clinical%20significance%20in%20the%20BRCA1%20and%20BRCA2%20breast%20cancer%E2%80%93predisposition%20genes&amp;volume=81&amp;publication_year=2007&amp;pages=873-883&amp;pmid=17924331&amp;doi=10.1086/521032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>
Goldgar D.E., Easton D.F., Deffenbaugh A.M., Monteiro A.N.A., Tavtigian S.V., Couch F.J.. 
Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am. J. Hum. Genet. 2004; 75:535–544.</cite> [<a href="https://doi.org/10.1086/424388" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1182042/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15290653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Integrated%20evaluation%20of%20DNA%20sequence%20variants%20of%20unknown%20clinical%20significance:%20application%20to%20BRCA1%20and%20BRCA2&amp;volume=75&amp;publication_year=2004&amp;pages=535-544&amp;pmid=15290653&amp;doi=10.1086/424388&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>
Goldgar D.E., Easton D.F., Byrnes G.B., Spurdle A.B., Iversen E.S., Greenblatt M.S.the IARC Unclassified Genetic Variants Working Group . 
Genetic evidence and integration of various data sources for classifying uncertain variants into a single model. Hum. Mutat. 2008; 29:1265–1272.</cite> [<a href="https://doi.org/10.1002/humu.20897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2936773/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18951437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Genetic%20evidence%20and%20integration%20of%20various%20data%20sources%20for%20classifying%20uncertain%20variants%20into%20a%20single%20model&amp;volume=29&amp;publication_year=2008&amp;pages=1265-1272&amp;pmid=18951437&amp;doi=10.1002/humu.20897&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>
Plon S.E., Eccles D.M., Easton D., Foulkes W.D., Genuardi M., Greenblatt M.S., Hogervorst F.B.L., Hoogerbrugge N., Spurdle A.B., Tavtigian S.V.et al.. 
Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum. Mutat. 2008; 29:1282–1291.</cite> [<a href="https://doi.org/10.1002/humu.20880" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3075918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18951446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Sequence%20variant%20classification%20and%20reporting:%20recommendations%20for%20improving%20the%20interpretation%20of%20cancer%20susceptibility%20genetic%20test%20results&amp;volume=29&amp;publication_year=2008&amp;pages=1282-1291&amp;pmid=18951446&amp;doi=10.1002/humu.20880&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>
Tavtigian S.V., Byrnes G.B., Goldgar D.E., Thomas A.. 
Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications. Hum. Mutat. 2008; 29:1342–1354.</cite> [<a href="https://doi.org/10.1002/humu.20896" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3938023/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18951461/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Classification%20of%20rare%20missense%20substitutions,%20using%20risk%20surfaces,%20with%20genetic-%20and%20molecular-epidemiology%20applications&amp;volume=29&amp;publication_year=2008&amp;pages=1342-1354&amp;pmid=18951461&amp;doi=10.1002/humu.20896&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>
Parsons M.T., Tudini E., Li H., Hahnen E., Wappenschmidt B., Feliubadaló L., Aalfs C.M., Agata S., Aittomäki K., Alducci E.et al.. 
Large scale multifactorial likelihood quantitative analysis of <em>BRCA1</em> and <em>BRCA2</em> variants: an ENIGMA resource to support clinical variant classification. Hum. Mutat. 2019; 40:1557–1578.</cite> [<a href="https://doi.org/10.1002/humu.23818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6772163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31131967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Large%20scale%20multifactorial%20likelihood%20quantitative%20analysis%20of%20BRCA1%20and%20BRCA2%20variants:%20an%20ENIGMA%20resource%20to%20support%20clinical%20variant%20classification&amp;volume=40&amp;publication_year=2019&amp;pages=1557-1578&amp;pmid=31131967&amp;doi=10.1002/humu.23818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>
Venkitaraman A.R.
Cancer suppression by the chromosome custodians, BRCA1 and BRCA2. Science. 2014; 343:1470–1475.</cite> [<a href="https://doi.org/10.1126/science.1252230" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24675954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Cancer%20suppression%20by%20the%20chromosome%20custodians,%20BRCA1%20and%20BRCA2&amp;volume=343&amp;publication_year=2014&amp;pages=1470-1475&amp;pmid=24675954&amp;doi=10.1126/science.1252230&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>
Carreira A., Hilario J., Amitani I., Baskin R.J., Shivji M.K.K., Venkitaraman A.R., Kowalczykowski S.C.. 
The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51. Cell. 2009; 136:1032–1043.</cite> [<a href="https://doi.org/10.1016/j.cell.2009.02.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2669112/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19303847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=The%20BRC%20repeats%20of%20BRCA2%20modulate%20the%20DNA-binding%20selectivity%20of%20RAD51&amp;volume=136&amp;publication_year=2009&amp;pages=1032-1043&amp;pmid=19303847&amp;doi=10.1016/j.cell.2009.02.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>
Shivji M.K.K., Mukund S.R., Rajendra E., Chen S., Short J.M., Savill J., Klenerman D., Venkitaraman A.R.. 
The BRC repeats of human BRCA2 differentially regulate RAD51 binding on single- versus double-stranded DNA to stimulate strand exchange. Proc. Natl. Acad. Sci. U.S.A. 2009; 106:13254–13259.</cite> [<a href="https://doi.org/10.1073/pnas.0906208106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2714763/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19628690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20U.S.A.&amp;title=The%20BRC%20repeats%20of%20human%20BRCA2%20differentially%20regulate%20RAD51%20binding%20on%20single-%20versus%20double-stranded%20DNA%20to%20stimulate%20strand%20exchange&amp;volume=106&amp;publication_year=2009&amp;pages=13254-13259&amp;pmid=19628690&amp;doi=10.1073/pnas.0906208106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>
Thorslund T., McIlwraith M.J., Compton S.A., Lekomtsev S., Petronczki M., Griffith J.D., West S.C.. 
The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA. Nat. Struct. Mol. Biol. 2010; 17:1263–1265.</cite> [<a href="https://doi.org/10.1038/nsmb.1905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4041013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20729858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Struct.%20Mol.%20Biol.&amp;title=The%20breast%20cancer%20tumor%20suppressor%20BRCA2%20promotes%20the%20specific%20targeting%20of%20RAD51%20to%20single-stranded%20DNA&amp;volume=17&amp;publication_year=2010&amp;pages=1263-1265&amp;pmid=20729858&amp;doi=10.1038/nsmb.1905&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>
Yuan S.-S.F., Lee S.-Y., Chen G., Song M., Tomlinson G.E., Lee E.Y.-H.P.. 
BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res. 1999; 59:3547–3551.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10446958/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=BRCA2%20is%20required%20for%20ionizing%20radiation-induced%20assembly%20of%20Rad51%20complex%20in%20vivo&amp;volume=59&amp;publication_year=1999&amp;pages=3547-3551&amp;pmid=10446958&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>
Lomonosov M., Anand S., Sangrithi M., Davies R., Venkitaraman A.. 
Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes Dev. 2003; 17:3017–3022.</cite> [<a href="https://doi.org/10.1101/gad.279003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC305253/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14681210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20Dev.&amp;title=Stabilization%20of%20stalled%20DNA%20replication%20forks%20by%20the%20BRCA2%20breast%20cancer%20susceptibility%20protein&amp;volume=17&amp;publication_year=2003&amp;pages=3017-3022&amp;pmid=14681210&amp;doi=10.1101/gad.279003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>
Schlacher K., Christ N., Siaud N., Egashira A., Wu H., Jasin M.. 
Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell. 2011; 145:529–542.</cite> [<a href="https://doi.org/10.1016/j.cell.2011.03.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3261725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21565612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Double-strand%20break%20repair-independent%20role%20for%20BRCA2%20in%20blocking%20stalled%20replication%20fork%20degradation%20by%20MRE11&amp;volume=145&amp;publication_year=2011&amp;pages=529-542&amp;pmid=21565612&amp;doi=10.1016/j.cell.2011.03.041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>
Bhatia V., Barroso S.I., García-Rubio M.L., Tumini E., Herrera-Moyano E., Aguilera A.. 
BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2. Nature. 2014; 511:362–365.</cite> [<a href="https://doi.org/10.1038/nature13374" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24896180/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=BRCA2%20prevents%20R-loop%20accumulation%20and%20associates%20with%20TREX-2%20mRNA%20export%20factor%20PCID2&amp;volume=511&amp;publication_year=2014&amp;pages=362-365&amp;pmid=24896180&amp;doi=10.1038/nature13374&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>
Shivji M.K.K., Renaudin X., Williams Ç.H., Venkitaraman A.R.. 
BRCA2 regulates transcription elongation by RNA polymerase II to prevent R-loop accumulation. Cell Rep. 2018; 22:1031–1039.</cite> [<a href="https://doi.org/10.1016/j.celrep.2017.12.086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5846855/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29386125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Rep.&amp;title=BRCA2%20regulates%20transcription%20elongation%20by%20RNA%20polymerase%20II%20to%20prevent%20R-loop%20accumulation&amp;volume=22&amp;publication_year=2018&amp;pages=1031-1039&amp;pmid=29386125&amp;doi=10.1016/j.celrep.2017.12.086&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>
Daniels M.J., Wang Y., Lee M., Venkitaraman A.. 
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science. 2004; 306:876–879.</cite> [<a href="https://doi.org/10.1126/science.1102574" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15375219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Abnormal%20cytokinesis%20in%20cells%20deficient%20in%20the%20breast%20cancer%20susceptibility%20protein%20BRCA2&amp;volume=306&amp;publication_year=2004&amp;pages=876-879&amp;pmid=15375219&amp;doi=10.1126/science.1102574&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>
Mondal G., Rowley M., Guidugli L., Wu J., Pankratz V.S., Couch F.J.. 
BRCA2 localization to the midbody by filamin A regulates CEP55 signaling and completion of cytokinesis. Dev. Cell. 2012; 23:137–152.</cite> [<a href="https://doi.org/10.1016/j.devcel.2012.05.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3419138/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22771033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dev.%20Cell&amp;title=BRCA2%20localization%20to%20the%20midbody%20by%20filamin%20A%20regulates%20CEP55%20signaling%20and%20completion%20of%20cytokinesis&amp;volume=23&amp;publication_year=2012&amp;pages=137-152&amp;pmid=22771033&amp;doi=10.1016/j.devcel.2012.05.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>
Han J., Ruan C., Huen M.S.Y., Wang J., Xie A., Fu C., Liu T., Huang J.. 
BRCA2 antagonizes classical and alternative nonhomologous end-joining to prevent gross genomic instability. Nat. Commun. 2017; 8:1470.</cite> [<a href="https://doi.org/10.1038/s41467-017-01759-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5684403/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29133916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=BRCA2%20antagonizes%20classical%20and%20alternative%20nonhomologous%20end-joining%20to%20prevent%20gross%20genomic%20instability&amp;volume=8&amp;publication_year=2017&amp;pages=1470&amp;pmid=29133916&amp;doi=10.1038/s41467-017-01759-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>
Spain B.H., Larson C.J., Shihabuddin L.S., Gage F.H., Verma I.M.. 
Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations. Proc. Natl. Acad. Sci. U.S.A. 1999; 96:13920–13925.</cite> [<a href="https://doi.org/10.1073/pnas.96.24.13920" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC24166/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10570174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20U.S.A.&amp;title=Truncated%20BRCA2%20is%20cytoplasmic:%20implications%20for%20cancer-linked%20mutations&amp;volume=96&amp;publication_year=1999&amp;pages=13920-13925&amp;pmid=10570174&amp;doi=10.1073/pnas.96.24.13920&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>
Yano K., Morotomi K., Saito H., Kato M., Matsuo F., Miki Y.. 
Nuclear localization signals of the BRCA2 protein. Biochem. Biophys. Res. Commun. 2000; 270:171–175.</cite> [<a href="https://doi.org/10.1006/bbrc.2000.2392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10733923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;title=Nuclear%20localization%20signals%20of%20the%20BRCA2%20protein&amp;volume=270&amp;publication_year=2000&amp;pages=171-175&amp;pmid=10733923&amp;doi=10.1006/bbrc.2000.2392&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>
Bork P., Blomberg N., Nilges M.. 
Internal repeats in the BRCA2 protein sequence. Nat. Genet. 1996; 13:22–23.</cite> [<a href="https://doi.org/10.1038/ng0596-22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8673099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Genet.&amp;title=Internal%20repeats%20in%20the%20BRCA2%20protein%20sequence&amp;volume=13&amp;publication_year=1996&amp;pages=22-23&amp;pmid=8673099&amp;doi=10.1038/ng0596-22&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>
Chen P.-L., Chen C.-F., Chen Y., Xiao J., Sharp Z.D., Lee W.-H.. 
The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc. Natl. Acad. Sci. U.S.A. 1998; 95:5287–5292.</cite> [<a href="https://doi.org/10.1073/pnas.95.9.5287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC20253/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9560268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20U.S.A.&amp;title=The%20BRC%20repeats%20in%20BRCA2%20are%20critical%20for%20RAD51%20binding%20and%20resistance%20to%20methyl%20methanesulfonate%20treatment&amp;volume=95&amp;publication_year=1998&amp;pages=5287-5292&amp;pmid=9560268&amp;doi=10.1073/pnas.95.9.5287&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>
Davies A.A., Masson J.-Y., McIlwraith M.J., Stasiak A.Z., Stasiak A., Venkitaraman A.R., West S.C.. 
Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell. 2001; 7:273–282.</cite> [<a href="https://doi.org/10.1016/s1097-2765(01)00175-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11239456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell&amp;title=Role%20of%20BRCA2%20in%20control%20of%20the%20RAD51%20recombination%20and%20DNA%20repair%20protein&amp;volume=7&amp;publication_year=2001&amp;pages=273-282&amp;pmid=11239456&amp;doi=10.1016/s1097-2765(01)00175-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>
Wong A.K.C., Pero R., Ormonde P.A., Tavtigian S.V., Bartel P.L.. 
RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene <em>brca2</em>. J. Biol. Chem. 1997; 272:31941–31944.</cite> [<a href="https://doi.org/10.1074/jbc.272.51.31941" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9405383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=RAD51%20interacts%20with%20the%20evolutionarily%20conserved%20BRC%20motifs%20in%20the%20human%20breast%20cancer%20susceptibility%20gene%20brca2&amp;volume=272&amp;publication_year=1997&amp;pages=31941-31944&amp;pmid=9405383&amp;doi=10.1074/jbc.272.51.31941&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>
Xia B., Sheng Q., Nakanishi K., Ohashi A., Wu J., Christ N., Liu X., Jasin M., Couch F.J., Livingston D.M.. 
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell. 2006; 22:719–729.</cite> [<a href="https://doi.org/10.1016/j.molcel.2006.05.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16793542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell&amp;title=Control%20of%20BRCA2%20cellular%20and%20clinical%20functions%20by%20a%20nuclear%20partner,%20PALB2&amp;volume=22&amp;publication_year=2006&amp;pages=719-729&amp;pmid=16793542&amp;doi=10.1016/j.molcel.2006.05.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>
Yang H., Jeffrey P., Miller J., Kinnucan E., Sun Y., Thoma N., Zheng N., Chen P.-L., Lee W.-H., Pavletich N.. 
BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science. 2002; 297:1837–1848.</cite> [<a href="https://doi.org/10.1126/science.297.5588.1837" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12228710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=BRCA2%20function%20in%20DNA%20binding%20and%20recombination%20from%20a%20BRCA2-DSS1-ssDNA%20structure&amp;volume=297&amp;publication_year=2002&amp;pages=1837-1848&amp;pmid=12228710&amp;doi=10.1126/science.297.5588.1837&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>
Gudmundsdottir K., Lord C.J., Witt E., Tutt A.N.J., Ashworth A.. 
DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells. EMBO Rep. 2004; 5:989–993.</cite> [<a href="https://doi.org/10.1038/sj.embor.7400255" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1299155/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15359272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20Rep.&amp;title=DSS1%20is%20required%20for%20RAD51%20focus%20formation%20and%20genomic%20stability%20in%20mammalian%20cells&amp;volume=5&amp;publication_year=2004&amp;pages=989-993&amp;pmid=15359272&amp;doi=10.1038/sj.embor.7400255&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>
Li J., Zou C., Bai Y., Wazer D., Band V., Gao Q.. 
DSS1 is required for the stability of BRCA2. Oncogene. 2006; 25:1186–1194.</cite> [<a href="https://doi.org/10.1038/sj.onc.1209153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16205630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=DSS1%20is%20required%20for%20the%20stability%20of%20BRCA2&amp;volume=25&amp;publication_year=2006&amp;pages=1186-1194&amp;pmid=16205630&amp;doi=10.1038/sj.onc.1209153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>
Jeyasekharan A.D., Liu Y., Hattori H., Pisupati V., Jonsdottir A.B., Rajendra E., Lee M., Sundaramoorthy E., Schlachter S., Kaminski C.F.et al.. 
A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization. Nat. Struct. Mol. Biol. 2013; 20:1191–1198.</cite> [<a href="https://doi.org/10.1038/nsmb.2666" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3796201/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24013206/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Struct.%20Mol.%20Biol.&amp;title=A%20cancer-associated%20BRCA2%20mutation%20reveals%20masked%20nuclear%20export%20signals%20controlling%20localization&amp;volume=20&amp;publication_year=2013&amp;pages=1191-1198&amp;pmid=24013206&amp;doi=10.1038/nsmb.2666&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>
Liu J., Doty T., Gibson B., Heyer W.-D.. 
Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA. Nat. Struct. Mol. Biol. 2010; 17:1260–1262.</cite> [<a href="https://doi.org/10.1038/nsmb.1904" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2952495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20729859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Struct.%20Mol.%20Biol.&amp;title=Human%20BRCA2%20protein%20promotes%20RAD51%20filament%20formation%20on%20RPA-covered%20single-stranded%20DNA&amp;volume=17&amp;publication_year=2010&amp;pages=1260-1262&amp;pmid=20729859&amp;doi=10.1038/nsmb.1904&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>
Zhao W., Vaithiyalingam S., San Filippo J., Maranon D.G., Jimenez-Sainz J., Fontenay G.V., Kwon Y., Leung S.G., Lu L., Jensen R.B.et al.. 
Promotion of BRCA2-dependent homologous recombination by DSS1 via RPA targeting and DNA mimicry. Mol. Cell. 2015; 59:176–187.</cite> [<a href="https://doi.org/10.1016/j.molcel.2015.05.032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4506714/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26145171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell&amp;title=Promotion%20of%20BRCA2-dependent%20homologous%20recombination%20by%20DSS1%20via%20RPA%20targeting%20and%20DNA%20mimicry&amp;volume=59&amp;publication_year=2015&amp;pages=176-187&amp;pmid=26145171&amp;doi=10.1016/j.molcel.2015.05.032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>
Ran F.A., Hsu P.D., Wright J., Agarwala V., Scott D.A., Zhang F.. 
Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013; 8:2281–2308.</cite> [<a href="https://doi.org/10.1038/nprot.2013.143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3969860/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24157548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Protoc.&amp;title=Genome%20engineering%20using%20the%20CRISPR-Cas9%20system&amp;volume=8&amp;publication_year=2013&amp;pages=2281-2308&amp;pmid=24157548&amp;doi=10.1038/nprot.2013.143&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>
Arnoult N., Correia A., Ma J., Merlo A., Garcia-Gomez S., Maric M., Tognetti M., Benner C.W., Boulton S.J., Saghatelian A.et al.. 
Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN. Nature. 2017; 549:548–552.</cite> [<a href="https://doi.org/10.1038/nature24023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5624508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28959974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Regulation%20of%20DNA%20repair%20pathway%20choice%20in%20S%20and%20G2%20phases%20by%20the%20NHEJ%20inhibitor%20CYREN&amp;volume=549&amp;publication_year=2017&amp;pages=548-552&amp;pmid=28959974&amp;doi=10.1038/nature24023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<span class="label">41.</span><cite>
Buisson R., Niraj J., Rodrigue A., Ho C.K., Kreuzer J., Foo T.K., Hardy E.J.-L., Dellaire G., Haas W., Xia B.et al.. 
Coupling of homologous recombination and the checkpoint by ATR. Mol. Cell. 2017; 65:336–346.</cite> [<a href="https://doi.org/10.1016/j.molcel.2016.12.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5496772/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28089683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell&amp;title=Coupling%20of%20homologous%20recombination%20and%20the%20checkpoint%20by%20ATR&amp;volume=65&amp;publication_year=2017&amp;pages=336-346&amp;pmid=28089683&amp;doi=10.1016/j.molcel.2016.12.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<span class="label">42.</span><cite>
Delgado J., Radusky L.G., Cianferoni D., Serrano L.. 
FoldX 5.0: working with RNA, small molecules and a new graphical interface. Bioinformatics. 2019; 35:4168–4169.</cite> [<a href="https://doi.org/10.1093/bioinformatics/btz184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6792092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30874800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=FoldX%205.0:%20working%20with%20RNA,%20small%20molecules%20and%20a%20new%20graphical%20interface&amp;volume=35&amp;publication_year=2019&amp;pages=4168-4169&amp;pmid=30874800&amp;doi=10.1093/bioinformatics/btz184&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<span class="label">43.</span><cite>
Cock P.J.A., Antao T., Chang J.T., Chapman B.A., Cox C.J., Dalke A., Friedberg I., Hamelryck T., Kauff F., Wilczynski B.et al.. 
Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics. 2009; 25:1422–1423.</cite> [<a href="https://doi.org/10.1093/bioinformatics/btp163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2682512/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19304878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Biopython:%20freely%20available%20Python%20tools%20for%20computational%20molecular%20biology%20and%20bioinformatics&amp;volume=25&amp;publication_year=2009&amp;pages=1422-1423&amp;pmid=19304878&amp;doi=10.1093/bioinformatics/btp163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<span class="label">44.</span><cite>
Farrugia D.J., Agarwal M.K., Pankratz V.S., Deffenbaugh A.M., Pruss D., Frye C., Wadum L., Johnson K., Mentlick J., Tavtigian S.V.et al.. 
Functional assays for classification of <em>BRCA2</em> variants of uncertain significance. Cancer Res. 2008; 68:3523–3531.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-07-1587" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2936780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18451181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=Functional%20assays%20for%20classification%20of%20BRCA2%20variants%20of%20uncertain%20significance&amp;volume=68&amp;publication_year=2008&amp;pages=3523-3531&amp;pmid=18451181&amp;doi=10.1158/0008-5472.CAN-07-1587&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<span class="label">45.</span><cite>
Guidugli L., Pankratz V.S., Singh N., Thompson J., Erding C.A., Engel C., Schmutzler R., Domchek S., Nathanson K., Radice P.et al.. 
A classification model for <em>BRCA2</em> DNA binding domain missense variants based on homology-directed repair activity. Cancer Res. 2013; 73:265–275.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-12-2081" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3537884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23108138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=A%20classification%20model%20for%20BRCA2%20DNA%20binding%20domain%20missense%20variants%20based%20on%20homology-directed%20repair%20activity&amp;volume=73&amp;publication_year=2013&amp;pages=265-275&amp;pmid=23108138&amp;doi=10.1158/0008-5472.CAN-12-2081&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<span class="label">46.</span><cite>
Kuznetsov S.G., Liu P., Sharan S.K.. 
Mouse embryonic stem cell–based functional assay to evaluate mutations in BRCA2. Nat. Med. 2008; 14:875–881.</cite> [<a href="https://doi.org/10.1038/nm.1719" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2640324/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18607349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&amp;title=Mouse%20embryonic%20stem%20cell%E2%80%93based%20functional%20assay%20to%20evaluate%20mutations%20in%20BRCA2&amp;volume=14&amp;publication_year=2008&amp;pages=875-881&amp;pmid=18607349&amp;doi=10.1038/nm.1719&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<span class="label">47.</span><cite>
Wu K., Hinson S.R., Ohashi A., Farrugia D., Wendt P., Tavtigian S.V., Deffenbaugh A., Goldgar D., Couch F.J.. 
Functional evaluation and cancer risk assessment of BRCA2 unclassified variants. Cancer Res. 2005; 65:417–426.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/15695382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Functional%20evaluation%20and%20cancer%20risk%20assessment%20of%20BRCA2%20unclassified%20variants&amp;volume=65&amp;publication_year=2005&amp;pages=417-426&amp;pmid=15695382&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<span class="label">48.</span><cite>
Kellogg E.H., Leaver-Fay A., Baker D.. 
Role of conformational sampling in computing mutation-induced changes in protein structure and stability. Proteins. 2011; 79:830–838.</cite> [<a href="https://doi.org/10.1002/prot.22921" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3760476/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21287615/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proteins&amp;title=Role%20of%20conformational%20sampling%20in%20computing%20mutation-induced%20changes%20in%20protein%20structure%20and%20stability&amp;volume=79&amp;publication_year=2011&amp;pages=830-838&amp;pmid=21287615&amp;doi=10.1002/prot.22921&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49">
<span class="label">49.</span><cite>
Strokach A., Corbi-Verge C., Kim P.M.. 
Predicting changes in protein stability caused by mutation using sequence-and structure-based methods in a CAGI5 blind challenge. Hum. Mutat. 2019; 40:1414–1423.</cite> [<a href="https://doi.org/10.1002/humu.23852" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6744338/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31243847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Predicting%20changes%20in%20protein%20stability%20caused%20by%20mutation%20using%20sequence-and%20structure-based%20methods%20in%20a%20CAGI5%20blind%20challenge&amp;volume=40&amp;publication_year=2019&amp;pages=1414-1423&amp;pmid=31243847&amp;doi=10.1002/humu.23852&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50">
<span class="label">50.</span><cite>
Shihab H.A., Gough J., Cooper D.N., Stenson P.D., Barker G.L.A., Edwards K.J., Day I.N.M., Gaunt T.R.. 
Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum. Mutat. 2013; 34:57–65.</cite> [<a href="https://doi.org/10.1002/humu.22225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3558800/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23033316/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Predicting%20the%20functional,%20molecular,%20and%20phenotypic%20consequences%20of%20amino%20acid%20substitutions%20using%20hidden%20Markov%20models&amp;volume=34&amp;publication_year=2013&amp;pages=57-65&amp;pmid=23033316&amp;doi=10.1002/humu.22225&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51">
<span class="label">51.</span><cite>
Wang Z., Moult J.. 
SNPs, protein structure, and disease. Hum. Mutat. 2001; 17:263–270.</cite> [<a href="https://doi.org/10.1002/humu.22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11295823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=SNPs,%20protein%20structure,%20and%20disease&amp;volume=17&amp;publication_year=2001&amp;pages=263-270&amp;pmid=11295823&amp;doi=10.1002/humu.22&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52">
<span class="label">52.</span><cite>
Shorthouse D., Hall M.W.J., Hall B.A.. 
Computational Saturation Screen Reveals the Landscape of Mutations in Human Fumarate Hydratase. J. Chem. Inf. Model. 2021; 61:1970–1980.</cite> [<a href="https://doi.org/10.1021/acs.jcim.1c00063" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33848143/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Chem.%20Inf.%20Model.&amp;title=Computational%20Saturation%20Screen%20Reveals%20the%20Landscape%20of%20Mutations%20in%20Human%20Fumarate%20Hydratase&amp;volume=61&amp;publication_year=2021&amp;pages=1970-1980&amp;pmid=33848143&amp;doi=10.1021/acs.jcim.1c00063&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53">
<span class="label">53.</span><cite>
Fowler J.C., King C., Bryant C., Hall M.W.J., Sood R., Ong S.H., Earp E., Fernandez-Antoran D., Koeppel J., Dentro S.C.et al.. 
Selection of oncogenic mutant clones in normal human skin varies with body site. Cancer Discov. 2021; 11:340–361.</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-20-1092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7116717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33087317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov.&amp;title=Selection%20of%20oncogenic%20mutant%20clones%20in%20normal%20human%20skin%20varies%20with%20body%20site&amp;volume=11&amp;publication_year=2021&amp;pages=340-361&amp;pmid=33087317&amp;doi=10.1158/2159-8290.CD-20-1092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54">
<span class="label">54.</span><cite>
Lee B., Richards F.M.. 
The interpretation of protein structures: Estimation of static accessibility. J. Mol. Biol. 1971; 55:379–400.</cite> [<a href="https://doi.org/10.1016/0022-2836(71)90324-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/5551392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Biol.&amp;title=The%20interpretation%20of%20protein%20structures:%20Estimation%20of%20static%20accessibility&amp;volume=55&amp;publication_year=1971&amp;pages=379-400&amp;pmid=5551392&amp;doi=10.1016/0022-2836(71)90324-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55">
<span class="label">55.</span><cite>
Carugo O.
Predicting residue solvent accessibility from protein sequence by considering the sequence environment. Protein Eng. 2000; 13:607–609.</cite> [<a href="https://doi.org/10.1093/protein/13.9.607" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11054454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Protein%20Eng.&amp;title=Predicting%20residue%20solvent%20accessibility%20from%20protein%20sequence%20by%20considering%20the%20sequence%20environment&amp;volume=13&amp;publication_year=2000&amp;pages=607-609&amp;pmid=11054454&amp;doi=10.1093/protein/13.9.607&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56">
<span class="label">56.</span><cite>
Zhou Q., Kojic M., Cao Z., Lisby M., Mazloum N.A., Holloman W.K.. 
Dss1 interaction with Brh2 as a regulatory mechanism for recombinational repair. Mol. Cell. Biol. 2007; 27:2512–2526.</cite> [<a href="https://doi.org/10.1128/MCB.01907-06" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1899899/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17261595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell.%20Biol.&amp;title=Dss1%20interaction%20with%20Brh2%20as%20a%20regulatory%20mechanism%20for%20recombinational%20repair&amp;volume=27&amp;publication_year=2007&amp;pages=2512-2526&amp;pmid=17261595&amp;doi=10.1128/MCB.01907-06&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57">
<span class="label">57.</span><cite>
Le H.P., Ma X., Vaquero J., Brinkmeyer M., Guo F., Heyer W.-D., Liu J.. 
DSS1 and ssDNA regulate oligomerization of BRCA2. Nucleic Acids Res. 2020; 48:7818–7833.</cite> [<a href="https://doi.org/10.1093/nar/gkaa555" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7641332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32609828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=DSS1%20and%20ssDNA%20regulate%20oligomerization%20of%20BRCA2&amp;volume=48&amp;publication_year=2020&amp;pages=7818-7833&amp;pmid=32609828&amp;doi=10.1093/nar/gkaa555&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58">
<span class="label">58.</span><cite>
Patterson G.H., Lippincott-Schwartz J.. 
Selective photolabeling of proteins using photoactivatable GFP. Methods. 2004; 32:445–450.</cite> [<a href="https://doi.org/10.1016/j.ymeth.2003.10.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15003607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Methods&amp;title=Selective%20photolabeling%20of%20proteins%20using%20photoactivatable%20GFP&amp;volume=32&amp;publication_year=2004&amp;pages=445-450&amp;pmid=15003607&amp;doi=10.1016/j.ymeth.2003.10.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59">
<span class="label">59.</span><cite>
Vartiainen M.K., Guettler S., Larijani B., Treisman R.. 
Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science. 2007; 316:1749–1752.</cite> [<a href="https://doi.org/10.1126/science.1141084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17588931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Nuclear%20actin%20regulates%20dynamic%20subcellular%20localization%20and%20activity%20of%20the%20SRF%20cofactor%20MAL&amp;volume=316&amp;publication_year=2007&amp;pages=1749-1752&amp;pmid=17588931&amp;doi=10.1126/science.1141084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60">
<span class="label">60.</span><cite>
Kragelund B.B., Schenstrøm S.M., Rebula C.A., Panse V.G., Hartmann-Petersen R.. 
DSS1/Sem1, a multifunctional and intrinsically disordered protein. Trends Biochem. Sci. 2016; 41:446–459.</cite> [<a href="https://doi.org/10.1016/j.tibs.2016.02.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26944332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Biochem.%20Sci.&amp;title=DSS1/Sem1,%20a%20multifunctional%20and%20intrinsically%20disordered%20protein&amp;volume=41&amp;publication_year=2016&amp;pages=446-459&amp;pmid=26944332&amp;doi=10.1016/j.tibs.2016.02.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61">
<span class="label">61.</span><cite>
Jeyasekharan A.D., Ayoub N., Mahen R., Ries J., Esposito A., Rajendra E., Hattori H., Kulkarni R.P., Venkitaraman A.R.. 
DNA damage regulates the mobility of Brca2 within the nucleoplasm of living cells. Proc. Natl. Acad. Sci. U.S.A. 2010; 107:21937–21942.</cite> [<a href="https://doi.org/10.1073/pnas.1009577107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3003017/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21098284/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20U.S.A.&amp;title=DNA%20damage%20regulates%20the%20mobility%20of%20Brca2%20within%20the%20nucleoplasm%20of%20living%20cells&amp;volume=107&amp;publication_year=2010&amp;pages=21937-21942&amp;pmid=21098284&amp;doi=10.1073/pnas.1009577107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62">
<span class="label">62.</span><cite>
Reuter M., Zelensky A., Smal I., Meijering E., van Cappellen W.A., de Gruiter H.M., van Belle G.J., van Royen M.E., Houtsmuller A.B., Essers J.et al.. 
BRCA2 diffuses as oligomeric clusters with RAD51 and changes mobility after DNA damage in live cells. J. Cell Biol. 2014; 207:599–613.</cite> [<a href="https://doi.org/10.1083/jcb.201405014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4259808/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25488918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cell%20Biol.&amp;title=BRCA2%20diffuses%20as%20oligomeric%20clusters%20with%20RAD51%20and%20changes%20mobility%20after%20DNA%20damage%20in%20live%20cells&amp;volume=207&amp;publication_year=2014&amp;pages=599-613&amp;pmid=25488918&amp;doi=10.1083/jcb.201405014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>gkab308_Supplemental_File</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8191791/bin/gkab308_supplemental_file.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (844.5KB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Nucleic Acids Research are provided here courtesy of <strong>Oxford University Press</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1093/nar/gkab308"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/gkab308.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.3 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/8191791/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/8191791/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8191791%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8191791/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC8191791/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC8191791/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/33978741/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC8191791/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/33978741/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC8191791/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/8191791/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="3DQ1HeXu4nnIV7R3RY4ogX3wcpaTF404FNget6q2l5R26dm47XsYN5Wcjhz6IPvz">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
